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ABSTRACT 
 
Tendons and ligaments insert into bone through a transitional tissue termed the enthesis 
which is susceptible to injury and difficult to repair.  Entheses contain a region of 
calcified fibrocartilage (CFC), however mineral-associated proteins in this tissue remain 
poorly characterized. Bone sialoprotein (BSP) is a phosphoprotein associated with 
mineralizing tissues. In these studies BSP was identified in the CFC of entheses by 
immunohistochemistry. Analysis of the entheses of Bsp-/- mice indicate abnormalities in 
the CFC. Compared to controls, the CFC of the quadriceps tendon enthesis is 28% and 41 
% longer in 15 week and 14 month old Bsp-/- mice, respectively. MicroCT and Raman 
spectroscopic analysis of the CFC in Bsp-/- mice demonstrate that mineral content is 
similar between genotypes. Mechanical studies show that the Bsp-/- patellar tendon is 
larger in cross-sectional area yet mechanically weaker. These data suggest BSP is 
involved in the regulation and growth of the CFC.  
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1.1 Mineralized Tissues 
 
Biomineralization refers to the processes by which organisms form minerals 
(Lowenstam and Weiner, 1989). It requires the selective extraction and uptake of 
elements from the local environment and their incorporation into functional structures 
under strict biological control. The earliest fossil evidence of biomineralization dates 
back 3.5 billion years (Lepot et al., 2008) and has since been observed in all five of the 
biological kingdoms (Lowenstam and Weiner, 1989). Mineralized tissues are biological 
matrices that have incorporated inorganic minerals such as calcium and phosphorus into 
their structure. Mineralized tissues serve a variety of functions. They can act as protective 
armor, such as a shell, they can be involved in cutting and grinding functions, such as 
teeth, and can offer support and stability, as in the skeleton. Perhaps the most 
recognizable, and by far the best characterized, mineralized tissue is that of mammalian 
bone, of which a brief description follows.  
Bone is a complex connective tissue composed of three main phases: the cellular 
phase, the inorganic phase, and the organic phase. The major cell types in bone are 
osteoblasts, osteocytes and osteoclasts.  Osteoblasts are anabolic cells associated with the 
secretion of matrix and the deposition of mineral. Osteocytes, derived from osteoblasts 
that have become entombed within the matrix of the bone, are associated with its 
regulation and homeostasis. Osteoclasts are catabolic cells involved in the resorption and 
remodeling of bone, releasing mineral and breaking down the extracellular matrix.  The 
mineral content of bone, constituting the inorganic phase, is largely hydroxyapatite (HA), 
a stable crystal of calcium phosphate with unit formula Ca10(PO4)6(OH)2. HA deposition 
is facilitated by osteoblasts into an organic matrix (the organic phase) primarily 
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comprised of type I collagen. Roughly 10% of this matrix consists of non-collagenous 
proteins which serve a variety of functions such as cell attachment and signaling, 
regulation of mineral formation, which includes nucleation, binding and inhibition, as 
well as structural functions.  
Bones form through two major processes: intramembranous ossification and 
endochondral ossification. Flat bones, such as the components of the skull and scapula 
form through intramembranous ossification in which mesenchymal tissues become 
mineralized without a cartilage intermediate. Long bones, such as the femur and 
humerus, form through the process of endochondral ossification. Endochondral 
ossification begins embryonically when cells of the mesenchyme condense in regions that 
will eventually become the long bones of the skeleton. These cells differentiate into 
chondrocytes and form a cartilaginous anlage rich in type II collagen. Cells in the central 
region of this structure begin to exit the cell cycle and enter hypertrophy, in which they 
swell in size and excrete extracellular matrix. Hypertrophic chondrocytes secrete 
angiogenic factors which promotes the invasion of blood vessels into the tissue. These 
blood vessels deliver precursor cells which differentiate into osteoblasts and osteoclasts, 
as well as blood and bone marrow-forming hematopoietic cells, to the developing bone. 
This creates a primary ossification center in the middle of the anlage from which the 
mineralization process begins. Osteoblasts promote mineral deposition, while osteoclasts 
remodel the mineralized cartilage, facilitating the formation of lamellar bone. At the 
terminals of the developing long bones, the epiphysis, secondary ossification centers also 
form, creating a sandwich of resting, proliferative and hypertrophic chondrocytes termed 
the epiphyseal growth plate. Proliferation, hypertrophy and mineralization of the 
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chondrocytes of the growth plate drive the elongation and growth of the bone, until the 
plates fuse at the end of puberty 
 
1.2 Biomineralization 
The exact mechanism by which HA is deposited into the type I collagen matrix of 
bone is not fully understood. Serum concentrations of Ca2+ and PO4
3- are above the 
solubility product constant of HA (Eidelman et al., 1987), however, they are kept from 
precipitating in the body by a variety of inhibitors of crystal formation. In bone, type I 
collagen fibrils are arranged in staggered arrays creating a periodic gap, call the hole 
zone, every 67 nm (Katz and Li, 1973). It is within these hole zones that the initiation of 
HA crystal formation takes place (Traub et al., 1992). It has been suggested that the 
aqueous compartment created by the collagen hole zone is sufficiently small to exclude 
large HA inhibitors, which leads to mineral deposition by the exclusion of inhibitors 
(Nudelman et al., 2010; Price et al., 2009).  Despite this evidence, type I collagen fibrils 
themselves are not sufficient to nucleate HA formation (Blumenthal et al., 1990; Hunter 
et al., 1986), indicating that some additional factor must be present to initiate HA crystal 
formation. Acidic collagen binding proteins have long been speculated to fulfill this role 
(Glimcher and Muir, 1984), of which members of the SIBLING protein family are the 
prime examples.  
 
1.3 SIBLINGs 
Members of the Small Integrin Binding LIgand, N-linked Glycoprotein 
(SIBLING) family are small phosphoproteins, often associated with mineralized tissues. 
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The SIBLINGs have flexible structures and extensive post-translational modifications. 
All members of the SIBLING family contain an RGD integrin-binding motif (Fisher et 
al., 2001; George and Veis, 2008). The SIBLING genes are grouped in a 375 kbp cluster 
on human chromosome 4 (Fisher and Fedarko, 2003) and mouse chromosome 5 (Crosby 
et al., 1996). The family is comprised of 5 members: Osteopontin (OPN), Bone 
Sialoprotein (BSP), Dentin Matrix Protein 1 (DMP1), Matrix Extracellular 
Phosphoglycoprotein (MEPE) and Dentin Sialophosphoprotein (DSPP) (Fisher and 
Fedarko, 2003; Fisher et al., 2001). Although the SIBLING proteins do not share a high 
degree of sequence similarity, an examination of their exon structure reveals that the 5 
genes are indeed related, likely resulting from gene duplication events and subsequent 
divergences, facilitated by their flexible structure (Fisher and Fedarko, 2003).  
All members of the SIBLING family seem to be involved with the regulation and 
control of biological mineral deposition, although in different ways. The SIBLING 
proteins are largely acidic, with isoelectric points ranging from 3.4-4.3, however MEPE 
differs from the rest of the group as it is highly basic with a pI of 9.2 (Fisher and Fedarko, 
2003) BSP, DMP1, DSPP are promoters of mineral deposition and are mostly found 
within mineralized tissues, with greater concentrations of BSP found in bone, while 
dentin contains greater amounts of DMP1 and DSPP (George and Veis, 2008). OPN and 
MEPE are potent inhibitors of HA formation and are expressed ubiquitously, likely to 
prevent ectopic calcification of soft tissues (George and Veis, 2008). Single knock-out 
animals for each of the SIBLINGS have been created, with each displaying alterations in 
the properties of their mineralized tissues, however the loss of a single SIBLING gene 
does not result in an inability to form mineralized tissue (George and Veis, 2008). This 
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suggests that the SIBLINGs work in concert with each other to control the process of 
biomineralization in vivo and a great deal of functional redundancy is present within the 
family. As the focus of this thesis is bone sialoprotein, an in depth discussion of BSP 
follows.  
 
1.4 Bone Sialoprotein 
BSP is an intrinsically disordered and extensively post-translationally modified 
phosphoprotein found in the mineralized tissues of bones and teeth. BSP was initially 
isolated from bone in 1963 as a 23-kDa sialic acid-containing glycoprotein (Herring and 
Kent, 1963)(Figure 1.1). By utilizing a dissociative extraction procedure, Fisher et al. 
isolated a 70-80 kDa variant from calf bone, representing full length native BSP complete 
with its post translational modifications (Fisher et al., 1983). The rat Bsp gene was first 
sequenced in 1988 by Oldberg et al. (Oldberg et al., 1988).  The amino acid sequences of 
BSP have since been deduced in a variety of mammalian species and show a high level of 
conservation, with specific domains showing identity approaching 90% (Goldberg and 
Hunter, 2012). 
 
1.4.1 Structure 
Mammalian BSP contains an average of 300 amino acids, 20% of which are Glu 
and 11% are Gly. Additionally a 16-residue signal sequence is present at the N-terminus. 
Unmodified BSP has a pI of 3.9. BSP’s calculated mass based on amino acid composition 
derived from the cDNA sequence is 33,549 Da; however, two independent MALDI-TOF  
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Figure 1.1 Schematic of bone sialoprotein. BSP is approximately 300 amino acids long. 
The collagen-binding sequence (yellow) spans residues 18-45. There are two poly-
glutamic acid sequences (red) responsible for HA nucleation. Finally, there is an integrin-
binding RGD sequence (blue) at the C-terminus.  
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mass spectroscopy studies of BSP found mean masses of 52.5 and 49.0 kDa (Wuttke et 
al., 2001; Zaia et al., 2001). Broad mass peaks were observed in both these studies, 
reflecting the significant heterogeneity of post-translation modifications on individual 
BSP molecules. Oligosaccharides comprise approximately 30% of BSP’s weight and 
BSP contains 23 sialic acid residues (Zaia et al., 2001). BSP (bovine) also contains 11 
identified phosphorylation sites, however not all of these sites appear to be 
phosphorylated on each molecule. MALDI-TOF mass spectroscopy studies on proteolytic 
digests of BSP indicate that on average BSP molecules contain 5.8 phosphorylated serine 
residues (Salih and Flückiger, 2004; Salih et al., 2002). BSP also contains several 
sulfated tyrosine residues located in the C-terminal region of the protein. Structural 
analyses of BSP utilizing circular dichroism spectropolarimetry, NMR and small-angle 
X-ray scattering indicate the loose, flexible structure of an intrinsically disordered protein 
(Fisher et al., 2001; Tye et al., 2003; Wuttke et al., 2001).   
 
1.4.2 Collagen Binding  
BSP binds to type I collagen fibrils with a high affinity (KD =12.1 nM) (Tye et al., 
2005). The highly conserved collagen-binding domain of BSP encompasses residues 18-
45 and is rich in hydrophobic and basic amino acids. The KD of BSP18-45 (150 nM) is 
weaker than that of native, full-length BSP however, indicating that other regions of the 
molecule are involved in stabilizing the interaction with collagen (Baht et al., 2008). 
Intermolecular forces involved in this binding appear to be comprised mostly of 
hydrophobic interactions, as elution of BSP with 1.0 M NaCl yielded little protein; 
however, elution with acetonitrile, which disrupts hydrophobic interactions, resulted in 
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the full release of BSP from a type I collagen affinity column (Baht et al., 2008).  The 
exact location that BSP binds to on the collagen molecule remains unknown, however 
BSP appears to localize to the hole regions of type I collagen fibrils (Fujisawa et al., 
1995),  which as previously mentioned are associated with early mineral formation 
(Fratzl et al., 1991; Traub et al., 1992).                                                                                                             
 
1.4.3 Hydroxyapatite Binding and Nucleation 
BSP’s many negatively charged groups confer HA binding properties. At 
physiological salt concentrations, native rat BSP bind ~60 Ca2+ ions per molecule with 
low affinity (Chen et al., 1992), however bone-derived porcine BSP’s affinity for HA is 
higher with a KD of ~0.9 μM (Goldberg et al., 2001). This affinity is largely attributed to 
the 2-3 contiguous Glu sequences present in the central region of the protein, as 
competitive binding studies using synthetic poly-Asp and poly-Glu peptides reduced 
BSP’s affinity for HA by 90% and 68% respectively (Goldberg et al., 2001). 
Additionally, mutation of these poly-Glu sequences to poly-Ala sequences reduced in 
vivo HA adsorption 4-fold (Wazen et al., 2007).  
BSP is also a potent nucleator of HA formation as demonstrated by Hunter and 
Goldberg using a steady-state agarose gel system (Hunter and Goldberg, 1993). This 
group went on to show that BSP’s poly-Glu sequences are largely responsible for HA 
formation (Goldberg et al., 1996). Synthetic peptides spanning BSP poly-Glu sequences 
can mediate HA formation on its own, and a 2.5 fold increase in nucleation activity is 
observed when these peptides are phosphorylated (Baht et al., 2010).  Correspondingly, 
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unmodified full length BSP also nucleates hydroxyapatite formation, however native BSP 
with its post translational modifications is ~100 fold more potent (Goldberg et al., 1996).  
 
1.4.4 Cell Attachment and Signaling 
Akin to its other SIBLING members, BSP contains an RGD integrin-binding 
motif, which is located towards its C-terminus. BSP’s RGD sequence is recognized by 
the αvβ3 integrin (Oldberg et al., 1988), a receptor identified on the surfaces of osteoblasts 
(Prince et al., 1991) and osteoclasts (Miyauchi et al., 1991; Ross et al., 1993) BSP-
mediated attachment of these cell types has been demonstrated respectively by 
Somerman et al. and Helfrich et al. (Helfrich et al., 1992; Somerman et al., 1988). Cell 
attachment of osteoblasts, fibroblasts, and chondrocytes is abolished by alteration to a 
KAE sequence (Gill et al., 2008; Gordon et al., 2007; Harris et al., 2000). Eukaryotic cell 
binding via an RGD-independent mechanism has also been described (Mintz et al., 
1993).   
BSP has been shown to promote osteoblast differentiation and mineral formation 
in cell culture (Cooper et al., 1998; Zhou et al., 1995). Furthermore, a reduction in 
mineralized nodules was observed when osteoblast-like cell cultures were treated with an 
anti-BSP antibody (Boskey et al., 2008). Overexpression of BSP in primary rat calvarial 
cells increased mineral formation and markers of osteoblast differentiation (Gordon et al., 
2007).  Treatment with BSP and osteogenic media of human bone marrow-derived cells 
resulted in a decrease in cell proliferation and promoted differentiation into osteoblasts 
(Xia et al., 2011).  
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BSP mediates Ca2+ signaling in osteoclasts through the αvβ3 integrin receptor 
(Paniccia et al., 1995, 1993) and can modulate their activity. BSP is involved in the 
generation of osteoclasts (Valverde et al., 2005, 2008) and stimulates in vitro bone 
resorption (Raynal et al., 1996), however it is not critical for this process (Malaval et al., 
2008).   
 
1.4.5 Tissue Distribution and Expression 
BSP expression is largely restricted to mineralized tissue. BSP has long been 
known to be expressed in osteoid tissue (Ganss et al., 1999) and has particularly strong 
expression in developing bone (Bianco et al., 1991). BSP is relatively uniform in its 
distribution throughout the bone, where it is likely bound to and entrapped by HA 
(Bianco et al., 1993; Chen et al., 1993; Kasugai et al., 1992; Riminucci et al., 1995) 
although BSP protein is particularly concentrated at the mineralization front (Bianco et 
al., 1993; Riminucci et al., 1995; Shapiro et al., 1993). Chen et al. showed BSP mRNA in 
rat tissue is abundant during times of de novo bone synthesis and mineralization in bone, 
dentin and cementum using northern blotting and in situ hybridization, however 
expression declines as the animals matured, with little mRNA detected in 100 day old 
rats (Chen et al., 1992). Thus, BSP’s expression and localization coincides with the 
formation of a mineralized matrix. BSP mRNA is abundant and easily detected in mature 
osteoblasts and osteocytes, however it is not present in pre-osteoblastic cells, indicating 
that BSP expression is induced upon differentiation (Bianco et al., 1991; Chen et al., 
1991). In line with its proposed role in de novo bone synthesis, BSP is also expressed by 
the hypertrophic chondrocytes within the epiphyseal growth plate (Bianco et al., 1991).  
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BSP expression has been detected in osteoclasts (Arai et al., 1995; Bianco et al., 1991), 
suggesting that it is involved in the modulation of mineral resorption.  
BSP is expressed in a variety of dental tissues, and may have a role in the 
formation and maintenance of teeth. BSP protein and mRNA have been detected in both 
dentin and cementum where it is expressed by odontoblasts and cementoblasts, 
respectively (Chen et al., 1993; Somerman et al., 1991). Cementum in particular is rich in 
BSP and BSP appears to be critical to the formation of acellular cementum (Foster et al., 
2013). Low levels of BSP have been detected in enamel and ameloblasts (Chen et al., 
1998). BSP has also been detected in three non-mineralized tissues; the trophoblastic 
cells of the human placenta (Bianco et al., 1991), salivary glands (Ogbureke and Fisher, 
2004) as well as platelets where it is probably endocytosed from the serum (Chenu and 
Delmas, 1992).  
 
1.4.6 In Vivo Function 
Due to its tissue distribution, expressional patterns and biochemical properties, 
BSP is thought to be involved in de novo bone synthesis. Specifically, BSP is believed to 
bind to collagen fibers and nucleate HA formation, while also recruiting osteogenic cells 
to sites of mineral formation (Ganss et al., 1999). A variety of in vivo studies support this 
hypothesis. When BSP and type I collagen are implanted into calvarial defects of rats, 
cell proliferation, osteoblast differentiation and mineral deposition are observed (Wang et 
al., 2006; Xu et al., 2007). BSP implantation into the pulp of rat molars may also 
stimulate dentinogenesis (Decup et al., 2000). 
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Mice lacking the Bsp gene (Bsp-/-) demonstrate reduced body size and weight with 
undermineralized fetal bones compared to wild-type littermates. At 4 months of age Bsp-/- 
mice display thinner cortical bones than wild type mice and have increased trabecular 
bone volume, however at 12 months few difference are apparent (Malaval et al., 2008). 
This suggests that the defects are transient, and mutant mice eventually "catch up" with 
their wild-type counterparts. Interestingly, mice which overexpress BSP via a CMV 
promoter also display thinner cortical bone and mild dwarfism, although trabecular bone 
volume is decreased in these animals (Valverde et al., 2008). Bone formation rate is 
decreased in Bsp-/- mice, as is bone resorption and osteoclastogenesis (Boudiffa et al., 
2010; Malaval et al., 2008). Conversely, BSP overexpressing mice display increased 
osteoclast activity and bone resorption (Valverde et al., 2008).  Osteoblasts isolated from 
Bsp-/- mice form fewer mineralizing colonies and express decreased levels of osteoblastic 
cell markers (Malaval et al., 2008); however BSP overexpressing mice also display 
decreased osteoblast populations and differentiation markers (Valverde et al., 2008).   
Repair of cortical defects drilled into the femur of Bsp-/- mice is slowed compared 
to wild type animals (Malaval et al., 2009), and marrow ablation models indicate primary 
bone formation is also delayed (Wade-Gueye et al., 2012). Embryonic mice at 15.5 days 
gestation display a delay in primary ossification (Holm et al., 2015).  In newborn Bsp-/- 
mice, microCT analysis of the skull revealed wider cranial sutures (Bouleftour et al., 
2014), suggesting a delay in membranous ossification.   
Recent studies suggest that there are alterations in the growth plates of these 
animals as well. Bouleftour et al. reported a thinner hypertrophic zone in the epiphyseal 
plate of 6 day old Bsp-/- mice and a thinner proliferative zone and thicker hypertrophic 
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zone at 3 weeks of age (Bouleftour et al., 2014).  Holm et al. also report growth plate 
abnormalities in the Bsp-/- mouse however this group observed an increase in the size of 
the resting zone with a reciprocal decrease in the size of the proliferative zone in newborn 
animals (Holm et al., 2015).  
A significant periodontal phenotype has recently been uncovered in the Bsp -/- 
mouse. The alveolar bone, into which the teeth are set, displays significant resorption in 
Bsp-/- mice (Foster et al., 2013). Briefly mentioned previously, acellular cementum is a 
thin mineralized tissue found along the apical portion of the root of the tooth, into which 
the periodontal ligament (PDL) inserts and anchors the tooth into alveolar bone. 
Immunohistochemical staining has demonstrated that acellular cementum is rich in BSP, 
and this tissue is significantly reduced in Bsp-/- mice (Foster et al., 2013). Additionally, 
the PDL in Bsp-/- mice is disorganized, with poorly aligned collagen fibers that do not 
properly insert into the tooth root (Foster et al., 2013). This phenotype spurred us to 
investigate other junctions between hard and soft tissues. 
 
1.5 The Enthesis 
Tendons and ligaments attach to bones through a transitional structure known as 
the enthesis, however authors have given the structure several other names such as 
osteotendious junction or simply the tendon-bone insertion (Benjamin and McGonagle, 
2001; Benjamin et al., 2002). Entheses are vital to locomotion and movement as they 
transmit the contractile force of skeletal muscles to their corresponding structures of the 
skeleton proper. Due to the immense loads these structures bear, as well as the large 
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differences in the mechanical properties of the two tissues they connect, entheses possess 
unique mechanics and biology.  
Entheses fall under two district categories which again have been called a variety 
of different names including periosteal-diaphyseal and chondroapophyseal attachments as 
well as indirect and direct attachments. For the purposes of this thesis we shall use the 
terms fibrous enthesis and fibrocartilaginous enthesis, respectively, for these structures 
since these are the consensus terms in the literature (Benjamin and McGonagle, 2001). 
 
1.5.1 Fibrous Entheses 
Fibrous insertions originating from tendon/ligaments usually occur over large 
areas where they connect either directly with the osteoid tissue of the bone or indirectly 
through the periosteum via perforating mineralized collagen fibers. When they attach to 
long bones, fibrous entheses usually occur at the diaphysis (Benjamin et al., 2002). Two 
examples of fibrous entheses are the tibial attachment of the medial collateral ligament of 
the knee and the deltoid attachment to the humerus in the shoulder. Fibrous entheses have 
received little research attention when compared to the fibrocartilaginous enthesis, which 
is likely due to the latter’s clinical relevance. Indeed, the focus of this thesis too, is the 
fibrocartilaginous enthesis. 
 
1.5.2 Fibrocartilaginous Entheses 
The far more common fibrocartilaginous enthesis is distinguished from the 
fibrous enthesis by the presence of fibrocartilage in the transition from tendon/ligament to 
bone and is of key clinical relevance as these are the structures most commonly damaged 
17 
 
 
in tears of the rotator cuff and ligaments of the knee. Examples of fibrocartilaginous 
entheses include the humeral attachment of the supraspinatus tendon (SST) and the 
insertion of the quadriceps femoris tendon (QCT) into the back of the patella (Figure 1.2). 
The fibrocartilaginous enthesis has traditionally been described as having four 
transitional zones: dense fibrous connective tissue of the tendon, uncalcified 
fibrocartilage, calcified fibrocartilage, and bone (Benjamin and McGonagle, 
2001)(Figure 1.3).  
The first zone of the fibrocartilaginous entheses is pure dense connective tissue of 
the tendon/ligament. This zone is primarily composed of linear type I collagen fibers with 
additional type III collagen, as well as small amounts of elastin and the proteoglycans 
biglycan and decorin. The major cells of this tissue are the elongated spindle-shaped 
fibroblasts which are responsible for the creation and maintenance of the tissue 
(Benjamin and Ralphs, 2000).  
Next follows a region of fibrocartilage, part of which is mineralized and part of 
which is not, the calcified fibrocartilage (CFC) and uncalcified fibrocartilage (UFC). 
Tendon gradually gives way to the UFC, which is composed mainly of type II collagen, 
although type I and III collagen are also present. Proteoglycans that have been identified 
in the UFC include decorin, biglycan, lumican, versican, and aggrecan and the cells that 
populate this region referred to as fibrochondrocytes (Fukuta et al., 1998; Kumagai et al., 
1994; Waggett et al., 1998). Fibrochondrocytes are isolated from one another and do not 
communicate with each other via gap junctions as the cells of the tendon and bone do, 
thus creating a barrier to communication between tenocytes and osteocytes 
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Figure 1.2 Anatomical location of selected fibrocartilaginous entheses. (A) Anterior 
view of the bones, muscles, tendons and ligaments of the knee. Insertion of the 
quadriceps femoris tendon into the back of the patella indicate (red arrow). (B) Posterior 
view of the muscles and bones of the shoulder. Insertion of the supraspinatus tendon into 
the humeral head indicated (red arrow).  
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This figure was adapted from Gray’s Anatomy for Students, Third Edition, Drake RL, Vogl AW, Mitchell 
AWM, Copyright Churchill Livingstone Elsevier (2015). Reproduced with permission from the publisher.  
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Figure 1.3 The transitional zones of the fibrocartilaginous enthesis.  
Fibrocartilaginous entheses have been classically divided into four zones: tendon, 
uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone. The tendon 
proper, made mostly of type I collagen, a region of fibrocartilage composed of type II 
collagen that is divided into an uncalcified and calcified region. The boundary is called 
the tidemark and indicates the edge of the mineralized tissue. The calcified fibrocartilage 
gives way to bone. Bar = 100 µm 
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(Ralphs et al., 1998). The UFC is more pliable than either the tendon or the CFC and it is 
thought that its primary function is stress dissipation and force dampening. This is 
evidenced by larger regions of UFC in entheses which vary more in their insertion angles 
during joint movement (Benjamin and McGonagle, 2001; Benjamin and Ralphs, 1998).  
A sharp boundary exists between the UFC and the CFC, termed the tidemark, and 
represents the maximum extent of the mineralized zone of the fibrocartilaginous enthesis. 
Using Raman spectroprobe analysis Schwartz et al. characterized the mineral gradient 
that occurs between the UFC and CFC at the tidemark in the mouse supraspinatus tendon 
insertion (Schwartz et al., 2012). Mineral increases from zero to maximal levels over a 
length of approximately 20 µm, a relatively narrow band as the total length of the 
calcified fibrocartilage of the murine supraspinatus tendon enthesis is roughly 100 µm. 
Furthermore, although the length of the CFC increases as the animal ages, the length of 
the mineral gradient remains the same. A separate study on the rat supraspinatus tendon 
enthesis found a gradient with length of roughly 100 µm (Wopenka et al., 2008), however 
it is not clear how the span of the gradient scales with the size of the animal.  
The mineral content of the CFC beyond the gradient zone is constant across its 
length (Schwartz et al., 2012), and the CFC has a slightly different matrix composition 
than the UFC. Type II collagen is much more abundant here, although type I collagen can 
still be detected. Furthermore, type X collagen is present in small amounts and its 
expression is not transient, as it is in the growth plate (Fujioka et al., 1997).  
 The major proteoglycan of the CFC is aggrecan, and notably this is the only 
region of the fibrocartilaginous enthesis where decorin is absent (Waggett et al., 1998). 
Interestingly no mineral associated proteins have yet been described in the CFC, although 
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Liu et al. observed asporin mRNA in the developing insertion of the patellar ligament to 
the tibia (Liu et al., 2013). Asporin is a member of the leucine rich repeat family of 
proteins, which includes the proteoglycans decorin and biglycan with collagen binding 
and HA binding properties (Kalamajski et al., 2009; Lorenzo et al., 2001). The CFC is 
intermediate in stiffness between tendon and bone and this characteristic is also thought 
to assist in stress dissipation during movement and loading (Benjamin et al., 2002; 
Fujioka et al., 1997).  
 The final zone of the fibrocartilaginous enthesis is bone, which has been 
described previously. The junction between the CFC and the lamellae of the bone is 
highly irregular, in contrast to the smooth straight line of the tidemark. This 
interdigitating of bone and CFC is thought to create a firm joining of these tissues, 
ultimately anchoring the tendon/ligament to the bone.  
 
1.5.3 Development 
The developmental pathways of the fibrocartilaginous enthesis are still being 
explored. The structure can first be identified in mice at embryonic day 13.5 while an 
apparently mature enthesis can be observed histologically as early as 21 days post-natal 
(Zelzer et al., 2014). As discussed previously, the fibrocartilaginous enthesis is a 
transitional tissue between bone and tendon, and as such, the origin of the enthesis is 
likely to include developmental components from the two tissues it eventually unites. 
Mentioned above, bone initially develops as a cartilaginous anlage composed of a 
condensation of mesenchymal cells that differentiate into chondrocytes. A key regulator 
of chondrocyte differentiation is the transcription factor Sox9 that is continually 
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expressed by all chondroprogenitors and chondrocytes during chondrogenesis (Akiyama 
et al., 2002; Dy et al., 2012; Ng et al., 1997; Zhao et al., 1997). Tenocyte differentiation 
is largely controlled by a basic helix loop helix transcription factor known as scleraxis 
(Scx) (Cserjesi et al., 1995; Murchison et al., 2007; Schweitzer et al., 2001).  
Generally tendons and ligaments insert into bone at boney eminences or 
protrusions, thus initial studies of the development of fibrocartilaginous entheses began 
with these structures. Intriguingly, cell lineage tracing indicates that bone eminences are 
not derived from the cartilaginous anlage of the bone but rather arise as a distinct unit 
derived from a pool of progenitors which are appended onto the developing bone (Blitz et 
al., 2013). Gene expression analysis of these progenitors reveals that they are positive for 
both Sox9 and Scx (Blitz et al., 2013; Sugimoto et al., 2013). This observation has led 
Zelzer et al. to propose the segregation model of enthesis development and cell 
differentiation (Zelzer et al., 2014). In this model, the bone eminence, Sox9 Scx double 
positive, progenitor cells differentiate and segregate into either the Sox9 positive cells of 
the enthesis fibrocartilage, or the Scx positive cells of the incoming tendon, uniting the 
two tissues without the need for a complex homing mechanism to direct a tendon to its 
proper attachment point.   
Other molecules have been identified to participate in the development of 
entheses. Transforming growth factor β (TGFβ) is necessary for tenocyte differentiation 
as evidenced by a lack of all tendinous tissue in mice which lack either the genes for 
Tgfβ1 and Tgfβ2, or its receptor TgfβrII (Pryce et al., 2009). The role of TGFβ in bone is 
poorly understood, as overexpression triggers chondrogenesis (Carrington et al., 1991; 
Chimal-Monroy and Díaz de León, 1997; Kulyk et al., 1989; Leonard et al., 1991; 
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Merino et al., 1998; Verrecchia and Mauviel, 2002) while lack of expression results in 
mild phenotypes (Seo and Serra, 2007; Spagnoli et al., 2007; Verrecchia and Mauviel, 
2002). At the developing enthesis, deletion of TgfβrII results in mice which lack bone 
eminence progenitor cells (Blitz et al., 2013), indicating that the TGFβ signaling pathway 
is required to commit mesenchymal cells to the enthesis development pathway. In 
contrast, the Scx/bone morphogenic protein 4 (BMP4) pathway does not seem to be 
involved in the specification of cells to enthesis development, as mice that lack these 
genes still possess Sox9 positive bone eminence progenitors. However, this pathway is 
involved in their differentiation as the bone eminence progenitors in both Scx-/- and Bmp4-
/- mice fail to differentiate and do not express type II collagen (Blitz et al., 2013). Other 
BMPs may be involved in enthesis development as well, as loss of the receptor for BMP2 
and BMP7 results in the failure of bone eminences of the humerus to form (Ovchinnikov 
et al., 2006). Dominant negative mutations in Bmp5 also cause alterations in bone 
eminence formation (Ho et al., 2008).  
The mechanism by which the developing enthesis mineralizes is largely unknown 
however the process is speculated to be similar to endochondral ossification of the long 
bones. Endochondral ossification is regulated in part by the Indian hedgehog (IHH) 
pathway, which also seems to play a role in enthesis development. IHH is expressed by 
hypertrophic chondrocytes as they terminally differentiate. IHH stimulates further 
chondrocyte proliferation by binding to the membrane receptor Patched (Ptch) which 
activates the membrane receptor Smoothened (Smo), resulting in the expression of 
parathyroid hormone-related protein (PTHrP). PTHrP inhibits chondrocyte maturation 
and mineralization and exercises negative feedback control on IHH, resulting in a loop in 
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which chondrocyte proliferation and hypertrophy can be finely controlled, based on the 
distance between the hypertrophic and proliferating chondrocytes. Expression of PTHrP 
and IHH has been detected in the developing enthesis, suggesting a developmental role 
for this pathway (Chen et al., 2006; Liu et al., 2012). Deletion of PTHrP in Scx 
expressing cells appears to deleteriously effect the ability of osteoclasts to excavate 
insertions for fibrous entheses (Wang et al., 2013). Constitutive expression of IHH in 
Scx-expressing cells leads to enthesis marker expression in the central region of the 
tendon (tendon midsubstance), such as type II collagen, where it is not normally 
expressed (Liu et al., 2013). Deletion of Smo in Scx-expressing cells results in 
chondrocyte impairment such that they fail to form fibrocartilage at the insertion. 
Furthermore, adult animals lacking Smo in these cells lack a tidemark, indicating 
mineralization is impaired (Liu et al., 2013). Although several studies have investigated 
the role of classical endochondral ossification signaling pathways in enthesis 
development, to date, protein regulators of mineralization remain wholly uncharacterized 
in the development and function fibrocartilaginous enthesis. 
Mechanical load has a significant influence on enthesis development. The role of 
physical cues in the development of the musculoskeletal system has been extensively 
studied (Galloway et al., 2013; Gkiatas and Lykissas, 2015). In the absence of muscle 
forces, defects in bone size, shape and mineralization can occur (Gomez et al., 2007; 
Mikic et al., 2000; Osborne et al., 2002; Sharir et al., 2011). Bone eminences too require 
mechanical force to fully mature as evidenced by transplantation experiments 
(Hamburger and Waugh, 1940; Hamburger, 1939, 1938). However, force is not required 
for the initiation of eminence formation as mice with induced muscle paralysis possess 
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stunted versions of these structures. It appears that instead, mechanical force drives 
growth and cell proliferation (Blitz et al., 2009; Kahn et al., 2009), and as a result, 
maturation of these structures in the absence of muscle force is delayed, with little or no 
fibrocartilage present at 8 weeks of age (Das et al., 2011; Schwartz et al., 2013; 
Thomopoulos et al., 2007). Disorganization of enthesis collagen fibres was also apparent 
at 8 weeks of age (Schwartz et al., 2013). Mineralization of the enthesis is also severely 
impaired by a loss of mechanical loading, causing an overall reduction in mineral content 
as well as altering the characteristics of the mineral crystals (Thomopoulos et al., 2007). 
Together these defects ultimately lead to a mechanically inferior tissue that failed under 
lower loads (Schwartz et al., 2013).  
 
1.5.4 Tissue Injury and Healing 
Tearing in tendons and ligaments is a common orthopedic injury, however, when 
the damage sustained involves entheseal tissue significant morbidity can occur. The 
muscles involved in the movement of the shoulder are collectively termed the rotator cuff 
and tears in these structures due to work and sports related injuries and aging are 
common (Ricchetti et al., 2012; Rothrauff and Tuan, 2014). Between 30,000 and 75,000 
rotator cuff repairs are performed annually in the United States (relevant Canadian 
statistics could not be identified) however the outcome of these surgeries remains poor 
(Ricchetti et al., 2012). Post-surgical repair failure rates for minor tears are as high as 
20% while the re-tear rate for massive rotator cuff tears are reported to reach a staggering 
94% (Derwin et al., 2012; Galatz et al., 2004). Repair failure is due in large part to a lack 
of tendon reintegration back into the bone.  
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 Various studies using animal models have demonstrated that reattachment of a 
torn tendon/ligament to bone does not result in the regeneration of an enthesis, but rather 
the formation of a fibrovascular scar (Aoki et al., 2001; Fujioka et al., 1998; Rodeo et al., 
1993; Thomopoulos and Williams, 2003). Although these therapies elicited a robust 
healing response, the resulting scar tissue did not have the same mechanical integrity as a 
true enthesis (Pierre et al., 1995; Thomopoulos and Williams, 2003). A detailed study 
using a rat rotator cuff injury model by Thomopoulos and Williams showed that a sharp 
boundary forms between the hard and soft tissues, and the continuous collagen fibers 
spanning the length of the native enthesis were absent and replaced by a disorganized 
matrix rich in type III collagen. Also absent was the gradation of mineral between soft 
tissue and bone, thought to be so crucial to stress dissipation. The authors report a tenfold 
reduction in the mechanical properties of this tissue (Thomopoulos and Williams, 2003).  
 Numerous therapies have been developed to overcome this problem, yet none so 
far have succeeded in creating a tissue with the same or greater mechanical properties of 
the native fibrocartilaginous enthesis. Further study of the composition and development 
of this structure, especially in regards to its mineralized portions, are required to develop 
better methods of reattaching tendons and ligaments to bones.  
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1.6 Purpose of Thesis 
A common joint injury is the avulsion or tear of a tendon or ligament from its 
attachment point on the skeleton, the fibrocartilaginous enthesis. These injuries cause 
significant morbidity, yet surgical and regenerative techniques fail to restore the full 
biomechanical properties of the original tissue. Our knowledge of the enthesis is 
incomplete, with the specifics of its composition and development still being elucidated. 
The calcified fibrocartilage in particular is poorly characterized. Although the presence 
and distribution of mineral in the CFC is vital to the mechanical properties and function 
of the tissue, a great void in our knowledge exists with regards to the mechanism of 
mineral deposition and the regulation of this process within it. Rationale for studying 
bone sialoprotein in the fibrocartilaginous enthesis is abundant. BSP’s presence in 
mineralizing tissues and its abilities to bind collagen, nucleate HA formation and interact 
with osteogenic cells are applicable and transferrable to the development of the 
fibrocartilaginous enthesis. In fact, numerous researchers have already highlighted the 
similarities and parallels present in the development of growth plates and 
fibrocartilaginous entheses. Furthermore, a significant defect caused by the loss of BSP 
has been identified at the site where the periodontal ligament attaches to the root of the 
tooth. The purpose of this thesis is to establish the presence of BSP in the 
fibrocartilaginous enthesis and to characterize the phenotype of this enthesis in the Bsp-/- 
mouse. It is hoped that a better understanding of the role BSP plays in the mineralization 
of this structure will further our understanding of its development and ultimately lead to 
more effective therapeutic and biomimetic techniques in the regeneration of the 
fibrocartilaginous enthesis.  
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2.1 Chapter Summary 
Tendons/ligaments insert into bone via a transitional structure, the enthesis, which is 
susceptible to injury and difficult to repair. Fibrocartilaginous entheses contain 
fibrocartilage in their transitional zone, part of which is mineralized. Mineral associated 
proteins within this zone have not been adequately characterized. Members of the Small 
Integrin Binding Ligand N-Linked Glycoprotein (SIBLING) family are acidic 
phosphoproteins expressed in mineralized tissues. Here we show two SIBLING proteins, 
bone sialoprotein (BSP) and osteopontin (OPN), are present in the enthesis. Histological 
analysis indicate that the calcified zone of Bsp-/- mice is 28% longer in the quadriceps 
tendon enthesis, however no difference is apparent in the supraspinatus tendon enthesis. 
In an analysis of mineral content within the calcified zone, microCT and Raman 
spectroscopy indicate that more mineral is present at the mineralization front of the 
quadriceps tendon enthesis in Bsp-/- mice, resulting in a steeper mineral gradient at the 
transition between soft and hard tissue. Mechanical testing of the patellar tendon indicate 
that while the tendons fail under similar loads, the Bsp-/- patellar tendon is 7.5% larger in 
cross sectional area than wild type tendons, resulting in a 16.5% reduction in mechanical 
strength. However, picrosirius red staining shows no difference in collagen organization. 
Data collected here indicate that BSP and OPN are present in the calcified fibrocartilage 
of murine entheses and suggest that BSP plays a regulatory role at the mineralization 
front in this structure. BSP appears to be involved in modulating the deposition of 
mineral at the mineralization front, ultimately controlling the extent to which the tissue 
grows and due to this, loss of BSP may cause a weakening of the tendon mechanical 
properties. BSP’s ability to modulate mineral deposition at the enthesis may ultimately 
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prove it to be a useful therapeutic molecule in the reattachment of tendons and ligaments 
to bone.  
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2.2 Introduction 
Members of the Small Integrin Binding Ligand N-linked Glycoprotein 
(SIBLING) protein family are associated with the mineralized tissues of the skeleton and 
dentition (Fisher and Fedarko, 2003).  SIBLINGs are anionic phosphoproteins with a 
flexible structure and extensive post-translational modifications. The family consists of 5 
members: bone sialoprotein (BSP), osteopontin (OPN), dentin matrix protein 1 (DMP1), 
dentin sialophosphoprotein (DSPP) and matrix extracellular phosphoglycoprotein 
(MEPE), with the encoding genes located in a syntenic gene locus on murine 
chromosome five (Fisher and Fedarko, 2003).  
BSP is a heavily glycosylated and phosphorylated protein that is expressed at the 
onset of mineralization in hard connective tissues (Goldberg and Hunter, 2012). In cell-
free systems, BSP has been demonstrated to be a potent nucleator of hydroxyapatite 
(HA), the principal mineral component of bone (Hunter and Goldberg, 1993). Nucleation 
and binding to HA by BSP is conferred by poly-glutamic acid sequences found in the 
central region of the protein (Hunter and Goldberg, 1993; Tye et al., 2003). BSP also 
contains an N-terminal collagen-binding domain and it is proposed that binding of BSP to 
collagen promotes HA nucleation (Baht et al., 2008; Tye et al., 2005). Finally, BSP 
contains an integrin-binding RGD motif, located towards the C-terminus, which promotes 
osteoblast differentiation and matrix mineralization (Gordon et al., 2007). 
Mice in which the Bsp gene has been ablated (Bsp-/-) have a variety of skeletal and 
dental defects. At 4 months of age, these mice display reduced long bone length and 
cortical thickness, and a lower rate of bone formation, but have higher trabecular bone 
density than wild type mice (Malaval et al., 2008). However, due to an incisor 
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malocclusion phenotype on hard diet, some of these defects are ameliorated if Bsp-/- mice 
are fed a soft food diet (Soenjaya et al., 2015). Further studies by the Malaval group 
showed that the Bsp-/-  mouse displays a delay of bone repair in cortical injury models 
(Monfoulet et al., 2010) and impaired bone formation and resorption in marrow ablation 
models (Wade-Gueye et al., 2012).  
More recently, a significant periodontal phenotype has been uncovered in the  
Bsp-/- mouse. Acellular cementum is a thin mineralized tissue found along the apical 
portion of the root of the tooth, into which the periodontal ligament (PDL) inserts. 
Immunohistochemistry shows that acellular cementum is rich in BSP, however in the 
Bsp-/- mouse there is a striking reduction in the amount of this tissue (Foster et al., 2013).  
Additionally, the Bsp-/- mouse PDL is disorganized, with poorly aligned collagen fibers 
that do not properly insert into the tooth root (Foster et al., 2015, 2013; Soenjaya et al., 
2015). However, insertion of the PDL collagen into alveolar bone appears normal (Foster 
et al., 2015).  
The defects observed in the PDL of the Bsp-/- mouse have spurred us to investigate 
other junctions between soft and mineralized tissue. Of particular interest is the enthesis, 
the transition site of tendon and ligament insertion into bone. Fibrocartilaginous entheses 
are found where tendons or ligaments attach to the epiphysis or apophysis of long bones 
(Benjamin and McGonagle, 2001). As such, they are present at several key sites involved 
in locomotion, such as where the supraspinatus tendon (SST) of the rotator cuff meets the 
epiphysis of the humerus, and where the quadriceps femoris tendon (QCT) inserts into 
the back of the patella.  
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Fibrocartilaginous entheses contain a fibrocartilage zone containing type II 
collagen and fibrochondrocytes at the interface between tendon and bone. As such, 
fibrocartilaginous entheses display 4 transitional zones: the dense connective tissue of the 
tendon, uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone. A 
sharp boundary occurs between the calcified and uncalcified fibrocartilage which is 
known as the tidemark. Entheses are largely avascular and as such have a limited 
potential for regeneration (Benjamin and McGonagle, 2001; Benjamin et al., 2002). Once 
torn away from bone, reattachment of a tendon or ligament is difficult. Indeed, the failure 
rates for repairs of massive rotator cuff tears remain high despite advances in surgical 
technique (Galatz et al., 2004). 
Given its HA nucleating and collagen binding properties, and the phenotype 
observed in the Bsp-/- mouse PDL, we hypothesize that BSP is present in 
fibrocartilaginous entheses and is involved in directing the mineralization and 
organization of these structures. In this study we show for the first time that the 
mineralized zones of murine fibrocartilaginous entheses contain the SIBLING proteins 
BSP and OPN, and that the loss of BSP results in structural, mineral and mechanical 
alterations in these entheses and attached tendons.  
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2.3. Materials and Methods  
2.3.1 Animals 
Animal care followed guidelines of the Canadian Council on Animal Care and 
Veterinary Services at the University of Western Ontario. Preparation and genotyping of 
Bsp-/- and wild-type mice, maintained on a mixed 129/CD1 background, were performed 
as described previously (Malaval et al., 2008). Opn-/- mice were obtained from Jackson 
Laboratory (JAX Stock number 004936, Sacramento, USA) and handled as described 
previously (Holm et al., 2014). All mice used in this study were fed a soft diet as outlined 
by Soenjaya et al. (Soenjaya et al., 2015). Animals used in this study were sacrificed by 
CO2 asphyxiation. All comparisons between genotypes were performed on male mice 
born in the same litter.  
2.3.2 Histology and Immunohistochemistry 
Wild type and Bsp-/- shoulder and knee joints from 15 week old mice were 
harvested and prepared for histology as described previously with alterations (Wang et 
al., 2007) . Briefly, tissue was fixed in neutral buffered formalin (10%) overnight at 4°C 
and were then decalcified in 0.65 M EDTA pH 7.4 at 37 °C for three weeks. Tissues were 
processed by University Hospital Pathology Core, London, ON, Canada, then embedded 
in paraffin and sectioned into 5 µm sections.  
Immunohistochemical analysis used in this study is as described previously 
(Foster et al., 2013; Holm et al., 2015). Briefly, following standard histological 
deparaffinization and rehydration, samples were treated with 3% hydrogen peroxide in 
methanol. Heat mediated antigen retrieval was performed in 0.1 M sodium citrate, pH 
6.0. Non-specific interactions were blocked using 5% goat serum in PBS for 1 hour at 
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room temperature. Sections were then treated with rabbit anti-mouse BSP serum 
(courtesy of Dr. Renny Franceschi, University of Michigan School of Dentistry, Ann 
Arbor, MI) or rabbit anti-mouse OPN serum (Courtesy of Dr. Larry Fisher, Bethesda, 
MD) overnight at 4˚C. Antibodies used in the study have been described previously 
(Foster et al., 2013; Ogbureke and Fisher, 2004). 1:200 dilutions in phosphate buffered 
saline with 5% goat serum were used for both the OPN and BSP antibodies. In the 
morning, sections were washed in PBS-T (0.1% Tween 20, Sigma-Aldrich) then treated 
with horseradish peroxidase-conjugated goat anti-rabbit IgG for 1 hour at room 
temperature. Sections were again washed with PBS-T, then treated with hydrogen 
peroxide and 3,3’-diaminobenzidine (DAB) (Vector Labs). Following DAB 
development, sections were counterstained with methyl green, dehydrated, cleared then 
mounted in xylene-based mounting medium.  
A basic hematoxylin and eosin staining technique was used for this study. 
Sections were stained for 10 seconds in Harris’s Hematoxylin (Sigma-Aldrich), then 
washed in running tap water for 10 min. Sections were then rinsed briefly in deionized 
water and stained with Eosin Y (Sigma-Aldrich) for 1 min. After another rinse in 
deionized water, sections were dehydrated and cleared, and then mounted in xylene-
based mounting medium. 
Von Kossa staining was performed as follows. Tissues were incubated in 2% 
silver nitrate for 48 hours. After the silver nitrate solution had permeated the tissues in 
their entirety silver ions were precipitated by reduction with sodium hypophosphite (0.6 
M) over the course of three days. By this method, elemental silver is deposited as a black 
precipitate in areas where hydroxyapatite is present. Tissues were then decalcified in 10% 
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formic acid over the course of 10 hours, followed by histological processing and 
sectioning as described above. After sectioning, tissues were incubated with 5% sodium 
thiosulfate to remove excess nonspecific staining. Sections were counterstained in alcian 
blue for 30 min, washed with deionized water, and then stained with nuclear fast red for 
10 min. Sections were then dehydrated and cleared followed by mounting in xylene-
based mounting medium.  
Picrosirius red staining was performed as follows.  Tissues were stained with 
Sirius red (Sigma-Aldrich) in saturated picric acid for 1 hour. Following staining, 
sections were washed in two changes of acidified water, then dehydrated and cleared. 
Specimens were imaged using circularly polarized light and collagen organization was 
characterized using the methods outlined by Rich and Whittaker (Rich and Whittaker, 
2005). 
 All solutions used in these protocols were made with Milli-Q deionized water 
unless otherwise indicated. 
 
2.3.3 Measurement of the calcified fibrocartilage zone 
The distance between the tidemark and bone of the SST and QCT entheses were 
measured across three transverses drawn parallel to the orientation of the collagen fibres, 
by two blinded individuals, in five 15 week-old male wild type and Bsp-/- litter mate 
pairs. The lengths of the triplicate measurements in each enthesis were averaged and 
these averages were compared between wild type and Bsp-/- mice using a parametric 
unpaired t-test.  
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2.3.4 Mechanical testing 
Immediately after euthanization, the hind limbs of 15 week old mice were 
removed and wrapped in PBS soaked gauze, then stored at -20°C prior to mechanical 
testing at the University of Pennsylvania. After thawing, the skin of the contralateral 
limbs was removed and the patella-patellar ligament-tibia complexes were carefully 
dissected under magnification, as described previously (Dunkman et al., 2013). The 
tendon cross-sectional area was measured using a custom laser-based device. The anterior 
surface of each tendon was speckle-coated with Verhoeff's stain to facilitate optical strain 
measurement. Prior to mechanical testing, the tibia was potted in polymethyl 
methacrylate (PMMA) and the patella was gripped with a custom aluminum fixtures. The 
specimens were then loaded into a materials testing system (Instron, Model 5848; 
Norwood, MA, USA) with a 10 N load cell. Throughout the testing, the system was 
submerged in a PBS bath maintained at 37°C. All specimens were tested using a 
modified version of the protocol outlined in (Dunkman et al., 2013). Briefly, the protocol 
consisted of preloading and preconditioning followed by 300 second hold and stress 
relaxation at 5% strain  After a return to gauge length, a ramp to failure at 0.1%/s was 
performed to measure the failure load of the specimens. For data analysis, modulus was 
calculated using optical tracking software for each tendon at three regions: (1) the patellar 
origin (1 mm distal to the patella), (2) tendon mid-substance and (3) tibial insertion (1 
mm proximal to tibial insertion). 
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2.3.5 Microcomputed Tomography  
Microcomputed tomography (microCT) analysis of the patella was performed 
using the eXplore Locus SP scanner (GE Healthcare, London, ON, Canada). 2D images 
were acquired using an X-ray tube with a voltage of 80 kVP and a current of 80 mA, with 
a 0.508 mm Al filter. The exposure interval time of the scanner was 1600 msec/frame at 4 
frames/view. In total, 900 views were obtained at 0.4 degrees angular increments. The 
data were reconstructed at a spatial resolution of 13.5 μm. All reconstructed data were 
calibrated with a cortical bone phantom (SB3; Gammex RMI, Milwaukee, WI, USA) 
with a hydroxyapatite equivalent of 1,100 mg/cc (White 1978), as well as water and air. 
Data were analyzed with MicroView ABA version 2.2 (GE Healthcare). 
For patellar analysis, 5 mice per genotype were used. Quantification of mineral 
density was performed on 3D cubical volumes of interest (VOIs; 20 isotropic voxel size) 
identified at the base area, where attachment of the quadriceps tendon occurred.   
For measurement of mineral density distribution along the tendon-to-bone 
insertion, three parallel transverse line measurements were obtained and averaged for 
each region of interest (ROI). The lines were defined manually along the CFC of the 
QCT enthesis.  
 
2.3.6 Raman spectroscopy 
Three pairs of male wild type and Bsp-/- littermates aged 15 weeks were 
euthanized, and the patellae were carefully dissected out following death. Patellae were 
then immersed in O.C.T (Tissuetek) and snap frozen.  Sagittal sections (10 μm) of the 
patellae were cut in a cryostat using a tungsten carbide blade. Sections were quickly 
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fixed, washed and dehydrated using an ethanol gradient, and then stored at -80˚C until 
scanning.  
The apparatus used for Raman spectroscopy was a LabRAM HR (Horiba-Jobin-
Yvon, Kyoto Japan) connected to an inverted optical microscope (IX71, Olympus, 
Tokyo, Japan) and interfaced with an atomic force microscope system stage 
(NanoWizard II Bioscience, JPK Instruments Inc., Berlin, Germany). The protocols used 
are as described  by (Schwartz et al. 2012). Peak intensity (height) was measured at 960 
cm-1, representing the P-O bonds of hydroxyapatite, and 2940 cm-1, representing the C-H 
bonds of collagen and other proteins.  After baseline correction, the P-O peak was 
normalized to the C-H peak, based on the assumption that the collagen content of the 
sample was constant at all points measured. Normalized 960 cm-1 hydroxyapatite P-O 
peak intensities were then compared between wild type and Bsp-/- samples. For each 
individual QCT enthesis, three separate linear measurements were made per enthesis, as 
described in the figure legends, lines of measurement were drawn from tidemark to bone 
in the orientation of the collagen fibres of the CFC. 
 
2.3.7 Statistical analyses 
Quantitative data are expressed as mean ± standard error. For enthesis length and 
mechanical comparisons, statistical analyses between experimental groups were 
performed using an unpaired parametric t-test. For microCT and Raman spectroscopy, 
differences between wild type and Bsp-/- mice was performed using repeated measures 
two way ANOVA. All statistical analysis were performed with Prism version 6.00 
(GraphPad Software, La Jolla, CA).   
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2.4 Results 
2.4.1 BSP and OPN are present in the mineralized tissues of fibrocartilaginous 
entheses 
Immunohistochemistry was performed to determine whether the SIBLING 
proteins BSP and OPN are present in the murine fibrocartilaginous entheses. BSP and 
OPN were detected in the calcified fibrocartilage of the QCT and SST entheses as well as 
the adjacent bone (Fig. 2.1). The absence of BSP and OPN immunostaining was 
confirmed in Bsp-/- and Opn-/- mice, respectively (Fig. 2.1).   
 
2.4.2 Bsp-/- mice exhibit defects in calcified fibrocartilage zone of the enthesis  
Von Kossa staining of the QCT and SST enthesis indicate approximately 
equivalent mineral content in the CFC of the wild type and Bsp-/- enthesis (Fig. 
2.2C,D,G,H).  However, the CFC is extended in QCT enthesis of Bsp-/- mice (Fig. 2.2A-
D).  The tidemark-to-bone length in the QCT enthesis measured at 178.8 ±15.5 μm for 
wild type and 229.1±17.5 μm for Bsp-/- mice (p<0.05, n=5). Surprisingly, no differences 
in the length of the CFC was observed in the SST enthesis of Bsp-/- and wild type mice 
(Fig. 2.2E-H).  
Due to the alteration in the CFC length of the Bsp-/- QCT enthesis, we analyzed 
the degree of mineralization along the length of the QCT enthesis. We initially utilized 
microCT in order to analyze the mineral distribution along the CFC of the Bsp-/- QCT 
enthesis.  MicroCT analysis demonstrated that radiodensity in the region corresponding 
to the CFC of the QCT enthesis increased rapidly then plateaued (Fig. 3A,B). No 
statistically significant difference was observed in radiodensityof the QCT CFC  
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Figure 2.1 SIBLING proteins are present in the calcified fibrocartilage of the SST 
and QCT entheses. Immunohistochemistry was performed to detect the presence of BSP 
and OPN protein (diaminobenzidine staining, brown) in the quadriceps tendon enthesis 
(QCT) and supraspinatus tendon enthesis (SST). BSP and OPN were detected in the 
calcified fibrocartilage of these entheses and are not present beyond a sharp boundary 
representing the tidemark between the CFC and UFC. Negative controls for BSP and 
OPN immunostaining of the SST and QCT entheses were performed on Bsp-/- and Opn-/- 
mice respectively. No nonspecific staining in the CFC on control mice was detected. 
Wild type and Bsp-/- animals are 15 week old, male, 129/CD1 mice; Opn-/- animals at 15 
week old, male, C57Bl/6 mice. CFC: calcified fibrocartilage, UFC: uncalcified 
fibrocartilage, bar = 100 μm  
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Figure 2.2 Mineral is deposited in the calcified fibrocartilage of Bsp -/ -  mice however 
the morphology of the clacified fibrocartilage is altered. (C,D,G,H) Von Kossa 
staining of the QCT and SST enthesis indicate approximately equivalent mineral content 
in the CFC of the wild type and Bsp-/- enthesis. (A,B,E,F) Staining with haematoxylin 
and eosin was used to assess gross morphology. An extenson of the calcifed 
fibrocartilage was observed, as measured from tidemark to bone (yellow arrow) in the 
QCT enthesis (n=5).  CFC: calcified fibrocartilage, UFC: uncalcified fibrocartilage, bar = 
100 μm 
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between wild type and Bsp-/- mice, suggesting that mineral content in the enthesis is 
similar (Fig. 3C,D). A slight increase in radiodensity was observed in the region 
immediately after the tidemark of the Bsp-/-  QCT enthesis compared to wild type, 
suggesting that higher levels of mineral are present in this region in the Bsp-/- mouse, 
however the difference was not statistically significant (Fig. 3A and B).  
Previously, the mineral gradient that occurs at the tidemark was measured to be 
approximately 20 m in length (Schwartz et al., 2012).  Of relevance, past studies have 
shown that a gradient of mineral is present along the enthesis where it is believed to play 
a role in stress dissipation (Genin et al., 2009; Schwartz et al., 2012). Since the resolution 
of the microCT analysis was limited to 11.5 m, to obtain more definitive analysis, 
Raman spectroscopy, which has a resolution of approximately 0.5-0.75 µm, was used to 
determine the gradient of mineral content. We used Raman spectrocopy to analyse the 
relative difference in intensity between the P-O bonds (peak at 960 cm-1)  of phosphate 
ions of HA to the organic C-H bonds (peak at 2940 cm-1) of the organic matter present in 
the tissue (mostly collagen), in Bsp-/- and wild type mice (Fig. 4A).  Raman analysis 
mirrored our microCT findings. Mineral content increases rapidly at the tidemark in both 
Bsp-/- and wild type mice then platued, with relatively equal levels of mineral being 
present in both sets of animals (Fig. 4B). Similar to microCT analysis, a minor increase in 
mineral is present near the tidemark in Bsp-/- mice (Fig. 4C,D) however due to the highly 
variable nature of Raman signals, statistical significance was not found (p>0.05).  
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Figure 2.3 MicroCT analyses indicates similar levels of mineralization in wild type 
and Bsp-/- QCT entheses.  (A) Three parallel lines (yellow arrows) per individual were 
drawn along the orientation of the collagen fibers inserting into bone to analyze changes 
in mineral density across the CFC’ then averaged. Lines span from points before the 
tidemark across the QCT enthesis and patellar bone into the marrow space. Position 0.00 
indicates where radiodensity crossed a threshold of 800 HU, which was estimated to be 
the tidemark. (B)  Radiodensity, which is an estimate of mineral content, across the 
length of the QCT enthesis was similar between wild type and Bsp-/- mice.  Radiodensity 
trended towards an increase in the region adjacent to the tidemark in Bsp-/- mice.  (C) 
MicroCT analysis was also performed to determine the overall radiodensity within a 20 
voxel region (isotropic voxel size of 11.5 μm) region of the CFC.  However, (D) the 
results showed no apparent changes in the overall mineral density of the Bsp-/- CFC zone 
compared to wild type. HU: Hounsfield units. 
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Figure 2.4 Raman spectroscopy shows that the mineral content in the QCT enthesis 
is comparable between wild type and Bsp-/- mice.  (A) 960 cm-1 hydroxyapatite peak 
intensities and 2940 cm-1 collagen peak intensities were analyzed at the tidemark and 5 
μm to either side. 960 cm-1 peaks are normalized to the 2940 cm-1 peak at each position 
measured. (B) Overall mineral content across the length of the  the QCT enthesis is 
similar between Bsp-/- and wild type mice. (C,D) Differences in mineral gradients are 
more apparent in comparisons of single transverses from individual wild type and Bsp-/- 
littermate pairs due to high variability in mineral to collagen ratios. 
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2.4.3 Mechanical testing suggests a weakened enthesis in Bsp-/- mice  
Defects noted in the CFC of the QCT enthesis prompted us to determine whether 
the strength of Bsp-/- enthesis is compromised. Mechanical testing performed on the 
patellar ligament, which links the patella to the proximal end of the tibia, indicated that 
its cross-sectional area was approximately 7.5% larger in Bsp-/- mice than wild type (Fig. 
2.5); however, the load required to fail the patellar tendon is similar for both genotypes, 
indicating that Bsp-/- mice have a weaker patellar tendon with a 16.5% lower failure stress 
compared to wild type (Fig. 2.5). Regardless of genotype, the patellar tendon failed at 
different positions along its length, with some failures occurring at the enthesis while 
others occurring at the tendon midsubstance and, in some cases, failing at more than one 
location. Unexpectedly, the local elastic moduli of Bsp-/- patellar tendon at three different 
regions: 1) patellar insertion, 2) midsubstance, and 3) tibial insertion were found to be 
similar to wild type (data not shown).  In addition, the overall percent relaxation and 
stiffness of the Bsp-/- patellar tendon were not affected (data not shown).   
 
2.4.4 Collagen organization is not affected by the loss of BSP 
Given the mechanical defect observed, as well as the disorganization seen in the 
periodontal ligament (Foster et al., 2013), collagen organization was assessed by 
picrosirus red staining. Images of wild type and Bsp-/- SST entheses and QCT entheses 
were taken using circularly polarized light (Fig. 2.6A). No striking difference in collagen 
organization was observed. Hue values, which are an index of collagen fiber thickness, 
were quantified using the protocol outlined by Rich and Whittaker (MacKenna and 
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Omens, 1994; Rich and Whittaker, 2005)(Fig. 2.6B). The proportions of pixels with 
specific hue values is not significantly shifted in Bsp-/- entheses when compared to 
wildtype in either the SST or QCT enthesis.  
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Figure 2.5  Bsp-/- mice exhibit alteration in patellar enthesis mechanical properties. 
At 15 weeks, Bsp-/- mice (n=11) revealed greater cross-sectional area compared to wild 
type. During tensile mechanical test, the Bsp-/- mice (n=10) patellar enthesis failed at a 
lower stress compared to wild type (n=12). Values shown represent means ± SEM; *p < 
0.05.  
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Figure 2.6 Collagen organization is not affected by loss of BSP. (A) SST and QCT 
entheses of wild type and Bsp-/- animals were stained using picrosirius red and viewed 
under circularly polarized light. Red-orange hues represent densely packed collagen 
fibers while greenish hues represent more loosely packed collagen fibers. CFC: calcified 
fibrocartilage, UFC: uncalcified fibrocartilage, bar = 100μm (B) Hue values for the SST 
were quantified. Each image (n=7 for wild type and Bsp-/-) was resolved into 256 bit 
colour. The calcified fibrocartilage was manually selected in each image and the number 
of pixels with each hue value was counted and divided by the total number of pixels in 
the selected area to determine the proportion of pixels with each hue. Hue proportions 
were then averaged. Red hues correspond to values between 240-250, orange 251-254 
and 1-3, yellow 4-12, green 13-56. Black pixels are given a value of 0 and white pixels a 
value of 255 and were omitted from analysis. Note that hues values of interest span the 
high and low end of the spectrum, but are presented here as a single peak.   
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2.5 Discussion 
BSP is an extracellular matrix protein present in mineralized tissues such as bone 
and tooth.  Here we demonstrate for the first time that BSP is also present in the CFC 
zone of the fibrocartilaginous enthesis. OPN was identified for the first time in this 
structure as well. The absence of BSP resulted in a lengthening of the CFC in the QCT 
enthesis. Furthermore, the Bsp-/- patellar tendon has an increased cross-sectional area and 
lower failure stress, however, the overall collagen organization and mineral content of the 
Bsp-/- enthesis appeared to be normal. Our findings suggest that BSP plays a role in the 
calcified fibrocartilage of the fibrocartilaginous enthesis.  
   
2.5.1 Role of altered calcified fibrocartilage zone of the Bsp-/- QCT enthesis. 
In this study, we have shown that BSP, a protein with demonstrated potency to 
promote mineral formation in vitro (Hunter and Goldberg, 1993), is present in the CFC 
zone of the enthesis. In the same tissue, we also demonstrated the presence of OPN, a 
close relative of BSP with inhibitory activity on HA formation (Hunter et al., 1994). The 
extracellular matrix composition of fibrocartilaginous entheses has been investigated 
previously (Gao et al., 1996; Waggett et al., 1998), however these studies primarily 
focused on the various collagens and proteoglycans. The distribution of mineral and 
orientation of the collagen fibers in the enthesis has been shown to influence its 
mechanical properties (Genin et al., 2009; Liu et al., 2012, 2011; Thomopoulos and 
Williams, 2003; Thomopoulos et al., 2005). However, there has been limited attempt to 
identify the mechanism by which the CFC is mineralized.  To our knowledge, the 
presence of mineral associated proteins has never been reported in the enthesis, although 
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recently asporin mRNA was identified in the enthesis fibrocartilage of 14-day-old mice 
(Liu et al., 2013).   
Our previous studies have shown that Bsp-/- mice lack acellular cementum, which 
led to PDL detachment and disorganization, and associated periodontal tissue breakdown 
such as resorption of alveolar bone and tooth surface (Foster et al., 2013). Minimizing the 
mechanical load during mastication, by changing to a soft diet, was not successful in 
ameliorating the rate of periodontal breakdown. In spite of this, reducing the mechanical 
load has significantly reduced the rate of incisor malocclusion, which affects the Bsp-/- 
mice ability to feed normally. By 8 weeks, long bone lengths normalize when Bsp-/- mice 
are fed a soft diet as does overall weight and serum alkaline phosphatase activity 
(Soenjaya et al., 2015). Based on the disorganization and detachment in the PDL, we 
initially hypothesized that the loss of BSP would have a negative effect on the collagen 
structure of the enthesis. However, no changes in the organization of collagen structure in 
the CFC of Bsp-/- mouse enthesis was observed. This observation suggests that BSP does 
not have a role in collagen organization.  
In the absence of BSP, the calcified fibrocartilage of the enthesis still forms and 
becomes mineralized. Thus, it is likely that other factors are compensating for the lack of 
BSP. Of relevance, our own studies have shown that in contrast to the poor PDL insertion 
into acellular cementum, insertion into the alveolar bone was not affected by the absence 
of BSP (Foster et al., 2015). It is of interest that at 15 weeks, the Bsp-/- QCT enthesis is 
greater in length (28% increase over wild type) compared to wild type at 15 weeks of 
age. In contrast, microCT and Raman spectroscopy analysis revealed that there is little 
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difference in the level of mineralization within the CFC between Bsp-/- and wild type 
mice. 
These results indicate mineral deposition and CFC growth are dysregulated in 
BSP’s absence. Recently it was shown that active mineralization occurs in a narrow band 
of Indian hedgehog (IHH) producing cells at the tidemark and that there is little turnover 
in enthesis fibrocartilage once formed (Dyment et al., 2015). Thus is seems likely that 
BSP is active at the tidemark. Interestingly, although BSP is thought to be a pro-
mineralization factor, the mineralized tissue in the Bsp-/- enthesis is larger in size. It is 
possible that in BSP’s absence another pro-mineralization factor is compensating for BSP 
and driving excess mineralization in the CFC. Another possibility is that BSP is involved 
in cell proliferation through its integrin-binding RGD motif and acts as a regulatory 
molecule on enthesis fibrochondrocytes. 
 Extensions of the mineralized zones of entheses have been documented in other 
studies. Polisson et al. have reported lengthening of the mineralized tissues of tendon and 
ligament insertions in humans suffering from X-linked hypophosphatemic osteomalacia 
(Polisson et al., 1985). Utilizing a murine model of this disorder in which PHEX, a gene 
involved in phosphate regulation, has been inactivated, Liang et al. have shown 
lengthening of the CFC in the QCT enthesis as well as in the Achilles tendon insertion 
into the calcaneus and the attachment of the patellar ligament to the tibial tubercle (Liang 
et al., 2009). Interestingly, a related disorder, autosomal recessive hypophosphatemia, is 
caused by a loss of function mutation in DMP1 (Lorenz-Depiereux et al., 2006), which is 
a close relative of BSP and part of the SIBLING protein family (Fisher and Fedarko 
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2003). Characterization of the Dmp1-/- fibrocartilaginous enthesis, however, has not yet 
been described. 
 
2.5.2 Bsp-/- patellar tendon exhibit weakened mechanical properties under load. 
Interestingly, the Bsp-/- patellar tendon cross-sectional area is greater than the wild 
type; however, under mechanical testing, the Bsp-/- patellar tendon failed at a similar 
applied load compared to wild type. This implies that the Bsp-/- patellar tendon is weaker 
since it requires lower stress, which is a function of both load and cross-sectional area, to 
fail. It is possible that a larger patellar tendon cross-sectional area observed in the Bsp-/- 
mouse is a compensatory mechanism which ensures that although the tendon is weaker, it 
can withstand the same loads. Similarly, Gao and Messer have hypothesized that the size 
of the CFC in an enthesis is related to the tensile load under which it is placed during its 
use (Gao and Messner, 1996). The increased size of the QCT CFC in the Bsp-/- mouse 
may also be compensating for a weakened tendon. Challenge experiments in which 
greater stress is placed on the Bsp-/- enthesis may provide insight as to how mechanical 
factors impact BSP’s role in enthesis mineralization. 
Furthermore, challenge experiments may reveal a more profound defect caused by 
the loss of BSP due to compromised repair processes in the enthesis. BSP has been 
implicated in the repair of several mineralized tissues. When BSP and collagen (prepared 
by crosslinking BSP to collagen, personal communication E. Salih) are implanted into 
calvarial defects of 7-8 week old rats, new bone formation is observed (Wang et al., 
2006). Cortical defects drilled into the femurs of Bsp -/- mice heal slowly when compared 
to wild type counterparts (Malaval et al., 2009; Monfoulet et al., 2010). Indeed, given 
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BSP’s collagen binding domain, hydroxyapatite nucleating properties and cell attachment 
and migration functions, BSP may be an attractive molecule to promote remineralization 
in common entheseal injuries such as rotator cuff tears, however further characterization 
of BSP’s role in enthesis development is required.  
Interestingly, there are many similarities between the development of 
fibrocartilaginous entheses and growth plates involved in endochondral ossification 
(Zelzer et al., 2014).  We and others have recently identified abnormalities in the growth 
plates of Bsp -/- mice as well as a delay in mineral deposition during endochondral 
ossification (Bouleftour et al., 2014; Holm et al., 2015). By 8 weeks however, Bsp -/- mice 
display a normal bone phenotype when fed a soft food diet (Soenjaya et al.¸ 2015). This 
suggests that a more pronounced phenotype may be present during the development of 
Bsp -/- fibrocartilaginous entheses. 
In combination, these data suggest that BSP may play a role in the mineralization 
of the CFC of the enthesis. Specifically, BSP seems to be acting at the mineralization 
front, the tidemark, of the fibrocartilaginous enthesis where it controls mineral deposition 
within a larger regulatory network. In BSP’s absence, other pro-mineralization factors 
appear to be compensating, resulting in excess mineralization at the tidemark and a 
dysregulation of CFC growth. These defects may ultimately contribute to the weakening 
of patellar tendon observed in the Bsp-/- mouse. 
  
75 
 
 
2.6 References 
 
Baht,  G.S., Hunter,  G.K., Goldberg,  HA, 2008. Bone sialoprotein–collagen interaction 
promotes hydroxyapatite nucleation. Matrix Biol. 27, 600–608. 
 
Benjamin,  M., McGonagle,  D., 2001. The anatomical basis for disease localisation in 
seronegative spondyloarthropathy at entheses and related sites. J. Anat. 199(Pt5), 503-26. 
 
Benjamin, M., Kumai, T., Milz, S., Boszczyk, B.M., Boszczyk, A.A., Ralphs, J.R., 2002. 
The skeletal attachment of tendons--tendon “entheses”. Comp. Biochem. Physiol., Part A 
Mol. Integr. Physiol. 133, 931–45. 
 
Bouleftour, W., Boudiffa, M., Wade-Gueye, N., Bouët, G., Cardelli, M., Laroche, N., 
Vanden-Bossche, A., Thomas, M., Bonnelye, E., Aubin, J., 2014. Skeletal Development 
of Mice Lacking Bone Sialoprotein (BSP)-Impairment of Long Bone Growth and 
Progressive Establishment of High Trabecular Bone Mass. PloS One 9, e95144. 
 
Dunkman, A.A., Buckley, M.R., Meinaltowski, M.J., Adams, S.M., Thomas, S.J., 
Satchell, L., Kumar, A., Pathmanathan, L., Beason, D.P., Iozzo, R.V., Birk, D.E., 
Soslowsky, L.J., 2013. Decorin expression is important for age-related changes in tendon 
structure and mechanical properties. Matrix Biol. 32(1), 3-13. 
 
Dyment N.A., Breidenbach A.P., Schwartz A.G., Russell R.P., Aschbacher-Smith L., Liu 
H., Hagiwara Y., Jiang R., Thomopoulos S., Butler D.L., Rowe D.W., 2015. GDF5 
Progenitors Give Rise To Fibrocartilage Cells That Mineralize Via Hedgehog Signaling 
To Form The Zonal Enthesis. Dev. Biol. doi: 10.1016/j.ydbio.2015.06.020 [Epub ahead 
of print]. 
 
Fisher, L., Fedarko, N., 2003. Six Genes Expressed in Bones and Teeth Encode the 
Current Members of the SIBLING Family of Proteins. Connect Tissue Res. 44, 3340. 
 
Foster,  B.L., Ao,  M., Willoughby,  C., Soenjaya,  Y., Holm,  E., 2015. Mineralization 
defects in cementum and craniofacial bone from loss of bone sialoprotein. Bone 78, 150-
64. 
 
Foster, B.L., Soenjaya, Nociti, F.H., Holm, Zerfas, P.M., Wimer, H.F., Holdsworth, 
D.W., Aubin, J.E., Hunter, G.K., Goldberg, H.A., Somerman, M.J., 2013. Deficiency in 
Acellular Cementum and Periodontal Attachment in Bsp Null Mice. J. Dent. Res. 92, 
166–72. 
 
Galatz,  L.M., Ball,  C.M., Teefey,  S.A., Middleton,  W.D., 2004. The outcome and 
repair integrity of completely arthroscopically repaired large and massive rotator cuff 
tears. The J. Bone Joint Surg. Am. 86-A(2), 219-24. 
 
Gao, J., Messner, K., 1996. Quantitative comparison of soft tissue-bone interface at 
chondral ligament insertions in the rabbit knee joint. J. Anat. 188 ( Pt 2), 367–73. 
76 
 
 
 
Gao J., Messner K., Ralphs J.R., Benjamin M., 1996. An immunohistochemical study of 
enthesis development in the medial collateral ligament of the rat knee joint. Anat. 
Embryol. 194(4), 399-406. 
 
Genin, G.M., Kent, A., Birman, V., Wopenka, B., Pasteris, J.D., Marquez, P.J., 
Thomopoulos, S., 2009. Functional grading of mineral and collagen in the attachment of 
tendon to bone. Biophys. J. 97, 976–85. 
 
Goldberg, H.A., Hunter, G.K., 2012. Functional domains of bone sialoprotein. In:  
 Goldberg M., ed. Phosphorylated extracellular matrix proteins of bone and  
 dentin. Vol. 2. Oak Park (IL): Bentham Science Publishers. p. 266–282. 
 
Gordon, J., Tye, C., Sampaio, A., Underhill, M., Hunter, G., Goldberg, H., 2007. Bone 
sialoprotein expression enhances osteoblast differentiation and matrix mineralization in 
vitro. Bone 41, 462-73. 
 
Holm, E., Aubin, J.E., Hunter, G.K., Beier, F., Goldberg, H.A,. 2015. Loss of bone 
sialoprotein leads to impaired endochondral bone development and mineralization. Bone 
71, 145-54. 
 
Holm, E., Gleberzon, J.S., Liao, Y., Sørensen, E.S., Beier, F., 2014. Osteopontin 
mediates mineralization and not osteogenic cell development in vitro. Biochem. J. 
464(3), 355–364. 
 
Hunter, G.K., Goldberg, H.A., 1993. Nucleation of hydroxyapatite by bone sialoprotein. 
Proc. Natl. Acad. Sci. U.S.A. 90, 8562–5. 
 
Hunter, G.K., Kyle, C.L., Goldberg, H.A., 1994. Modulation of crystal formation by bone 
phosphoproteins: structural specificity of the osteopontin-mediated inhibition of 
hydroxyapatite formation. Biochem. J. 300(Pt 3), 723-8. 
 
Liang, G., Katz, L., Insogna, K., Carpenter, T., Macica, C., 2009. Survey of the 
Enthesopathy of X-Linked Hypophosphatemia and Its Characterization in Hyp Mice. 
Calcif. Tissue Int. 85(3), 235-46. 
 
Liu, C.F., Aschbacher-Smith, L., Barthelery, N., Dyment, N., Butler, D., Wylie, C., 2012. 
Spatial and Temporal Expression of Molecular Markers and Cell Signals During Normal 
Development of the Mouse Patellar Tendon. Tissue Eng. Part A 18, 598–608. 
 
Liu, C.F., Breidenbach, A., Aschbacher-Smith, L., Butler, D., Wylie, C., 2013. A Role 
for Hedgehog Signaling in the Differentiation of the Insertion Site of the Patellar Tendon 
in the Mouse. PLoS One. 8, e65411. 
 
77 
 
 
Liu, Y., Thomopoulos, S., Chen, C., Birman, V., Buehler, MJ., Genin, GM. 2013. 
Modelling the mechanics of partially mineralized collagen fibrils, fibres and tissue. J. R. 
Soc. Interface. 11(92), 20130835. 
 
Liu, Y., Birman, V., Chen, C., Thomopoulos, S., Genin, G., 2011. Mechanisms of 
Bimaterial Attachment at the Interface of Tendon to Bone. J. Eng. Mater. Technol. 133, 
011006. 
 
Lorenz-Depiereux, B., Bastepe, M., Benet-Pagès, A., Amyere, M., Wagenstaller, J., 
Müller-Barth, U., Badenhoop, K., Kaiser, S.M., Rittmaster, R.S., Shlossberg, A.H., 
Olivares, J.L., Loris, C., Ramos, F.J., Glorieux, F., Vikkula, M., Jüppner, H., Strom, 
T.M., 2006. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone 
matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248–50. 
 
MacKenna,  D.A., Omens,  J.H., 1994. Contribution of collagen matrix to passive left 
ventricular mechanics in isolated rat hearts. Am. J. Physiol. 266(3 Pt 2), H1007-18. 
 
Malaval, L., Monfoulet, L., Fabre, T., Pothuaud, L., Bareille, R., Miraux, S., Thiaudiere, 
E., Raffard, G., Franconi, J.-M., Lafage-Proust, M.-H., Aubin, J., Vico, L., Amédée, J., 
2009. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long 
bone. Bone 45(5), 853-61. 
 
Malaval, L., Wade-Guéye, N., Boudiffa, M., Fei, J., Zirngibl, R., Chen, F., Laroche, N., 
Roux, J.P., Burt-Pichat, B., Duboeuf, F., Boivin, G., Jurdic, P., Lafage-Proust, M.H., 
Amédée, J., Vico, L., Rossant, J., Aubin, J., 2008. Bone sialoprotein plays a functional 
role in bone formation and osteoclastogenesis. J. Exp. Med. 205(5), 1145-53. 
 
Monfoulet, L., Malaval, L., Aubin, J.E., Rittling, S.R., Gadeau, A.P., Fricain, J.C., 
Chassande, O. 2010. Bone sialoprotein, but not osteopontin, deficiency impairs the 
mineralization of regenerating bone during cortical defect healing. Bone 46(2), 447-52. 
 
Polisson, R.P., Martinez, S., Khoury, M., Harrell, R.M., Lyles, K.W., Friedman, N., 
Harrelson, J.M., Reisner, E., Drezner, M.K., 1985. Calcification of entheses associated 
with X-linked hypophosphatemic osteomalacia. N. Engl. J. Med. 313, 1–6. 
 
Rich,  L., Whittaker,  P., 2005. Collagen and picrosirius red staining: a polarized light 
assessment of fibrillar hue and spatial distribution. Braz. J. Morphol. Sci. 22, 97–104. 
 
Schwartz, A.G., Pasteris, J.D., Genin, G.M., Daulton, T.L., Thomopoulos, S., 2012. 
Mineral distributions at the developing tendon enthesis. PloS One 7, e48630. 
 
Soenjaya, Y., Foster, B.L., Nociti Jr. , F.H., Ao, M., Holdsworth, D.W., Hunter, G.K., 
Somerman, M.J., Goldberg, H.A., 2015. Mechanical Forces Exacerbate Periodontal 
Defects in BSP-null mice. J. Dent. Res. pii: 0022034515592581. [Epub ahead of print] 
 
78 
 
 
Thomopoulos,  S., Williams,  G.R., 2003. Tendon to bone healing: differences in 
biomechanical, structural, and compositional properties due to a range of activity levels. 
J. Biochem. Eng. 125(1), 106-13. 
 
Thomopoulos, S., Marquez, J., Weinberger, B., Birman, V., Genin, G., 2005. Collagen 
fiber orientation at the tendon to bone insertion and its influence on stress concentrations. 
J. Biomech. 39, 1842–51. 
 
Tye, C.E., Hunter, G.K., Goldberg, H.A. 2005. Identification of the type I collagen-
binding domain of bone sialoprotein and characterization of the mechanism of 
interaction. J. Biol. Chem. 280(14), 13487-92. 
 
Tye, C.E., Rattray, K.R., Warner, K.J., Gordon, J.A., Sodek, J., Hunter, G.K., Goldberg, 
H.A. 2003. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J 
Biol. Chem. 278(10), 7949-55. 
 
Wade-Gueye, N., Boudiffa, M., Vanden-Bossche, A., Laroche, N., Aubin, J., Vico, L., 
Lafage-Proust, M.-H., Malaval, L., 2012. Absence of bone sialoprotein (BSP) impairs 
primary bone formation and resorption: The marrow ablation model under PTH 
challenge. Bone 50(5), 1064-73. 
 
Waggett, A.D., Ralphs, J.R., Kwan, A.P., Woodnutt, D., Benjamin, M. 1998. 
Characterization of collagens and proteoglycans at the insertion of the human Achilles 
tendon. Matrix Biol. 16(8), 457-70. 
 
Wang, G., Woods, A., Agoston, H., Ulici, V., Glogauer, M., Beier, F., 2007. Genetic 
ablation of Rac1 in cartilage results in chondrodysplasia. Dev. Biol. 306, 612–623. 
 
Wang, J., Zhou, H.Y., Salih, E., Xu, L., Wunderlich, L., Gu, X., Hofstaetter, J., Torres, 
M., Glimcher, M., 2006. Site-Specific In Vivo Calcification and Osteogenesis Stimulated 
by Bone Sialoprotein. Calcif. Tissue. Int. 79, 179–89. 
 
Zelzer, E., Blitz, E., Killian, M., Thomopoulos, S., 2014. Tendon‐ to‐ bone attachment: 
From development to maturity. Birth Defects Res. C Embryo Today 102, 101–12. 
  
79 
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
 
ELUCIDATING THE ROLE OF BONE SIALOPROTEIN IN THE 
MURINE ENTHESIS DURING DEVELOPMENT AND AGEING  
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3.1 Chapter Summary 
Tendons and ligaments insert into bone through a transitional structure termed the 
enthesis which features a region of fibrocartilage, part of which is mineralized. The 
mechanism by which this tissue becomes mineralized, however, is poorly characterized. 
Recently, bone sialoprotein (BSP), an acidic phosphoprotein associated with mineralizing 
tissues, was identified in the calcified fibrocartilage (CFC) of the enthesis, and loss of 
BSP resulted in alterations in this tissue in 15 week-old mice. The calcified fibrocartilage 
of Bsp-/- mice is 28% longer than wild type in the quadriceps tendon enthesis (QCT) 
although overall mineral content within the CFC is similar between genotypes. Bsp-/- 
mice possess defects in endochondral ossification and have abnormal growth plates. 
Enthesis development has been suggested to parallel growth plate development in a 
number of ways. As such, characterization of the Bsp-/- enthesis in juvenile animals is 
warranted to elucidate BSP’s role in this tissues development. Presented is a histological 
characterization of the supraspinatus tendon (SST) enthesis and the QCT enthesis of wild 
type and Bsp-/- mice at ages of 14 days, 21 days and 14 months. BSP and OPN are not 
present in either enthesis at 14 days of age. Small amounts of both proteins were detected 
by immunohistochemistry in the SST enthesis at 21 days of age. No differences in the 
general morphology were observed between Bsp-/- and wild type tissues in the QCT and 
SST entheses at either 14 or 21 days of age. Mineral content, as shown by von Kossa 
staining, and collagen organization, as assayed by picrosirius red staining, were also 
unaffected. At 14 months of age the Bsp-/- QCT CFC is longer than in wild type mice and 
the difference between Bsp-/- and wild type is larger than at 15 weeks, however no other 
differences were apparent. Data presented here indicate that loss of BSP has little effect 
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on the 14 and 21 day old entheses however loss of BSP appears to cause a dysregulation 
of CFC growth that continues well into adulthood.  
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3.2 Introduction 
 Tendons and ligaments transition into bone through a specialized tissue termed 
the enthesis. Fibrocartilaginous entheses are the most common category of entheses in the 
body and are commonly found at the insertions of tendons, which are connected to 
muscles involved in locomotion, into the epiphysis of long bones. As such, 
fibrocartilaginous entheses are of critical importance in efficient force transduction from 
skeletal muscles to the limbs. In order to effectively connect the soft, pliable material that 
makes up tendons and ligaments to the rigid structure of bone, fibrocartilaginous entheses 
transition through a region of fibrocartilage, part of which is mineralized. Thus 
fibrocartilaginous entheses have been classically described as have four zones: the tendon 
proper, uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone 
(Benjamin and McGonagle, 2001).  
 Bone sialoprotein (BSP) is an acidic phosphoprotein with a flexible structure and 
belongs to the Small Intergrin Binding Ligand N-Linked Glycoprotein (SIBLING) family 
of proteins (Fisher and Fedarko, 2003; Ganss et al., 1999). BSP has potent hydroxyapatite 
nucleating properties (Hunter and Goldberg, 1993), and binding of BSP to collagen is 
thought to promote matrix mineralization (Baht et al., 2008). Previously, BSP was 
detected in enthesis CFC and defects were identified in the 15 week old Bsp-/- mouse 
quadriceps tendon (QCT) enthesis. The calcified fibrocartilage (CFC) of the enthesis was 
28% longer in the Bsp-/- mouse, as measured from tidemark to bone. No changes were 
evident in the supraspinatus tendon (SST) enthesis.  The Bsp-/- patellar tendon is 7.5% 
larger in cross-sectional area than the wild type; however, this tendon has a failure stress 
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that is 16.5% lower than wild type indicating that while Bsp-/- tendons are larger, they are 
also mechanically weaker.  
BSP’s expression and localization coincides with the initial formation of a 
mineralized matrix in both intramembranous and endochondral ossification (Bianco et al., 
1991), and BSP is expressed by the hypertrophic chondrocytes within the epiphyseal 
growth plate (Chen et al., 1992), among other mineralized tissue associated cells. 
Interestingly, there are many similarities between the development of fibrocartilaginous 
entheses and growth plates involved in endochondral ossification (Zelzer et al., 2014). 
We and others have recently identified abnormalities in the growth plates of Bsp -/- mice 
as well as a delay in mineral deposition during endochondral ossification (Bouleftour et 
al., 2014; Holm et al., 2015). This suggests that a more pronounced phenotype may be 
present during the early development of Bsp -/- fibrocartilaginous entheses. Additionally, 
the extension in the QCT CFC observed at 15 weeks suggests that enthesis mineralization 
continues over a longer time period in the Bsp-/- mouse. An examination of an older time 
point beyond 15 weeks of age would provide additional insight into this observation. 
Presented is a histological characterization of Bsp -/- enthesis at three additional time 
points, 14 days post-natal, 21 days post-natal, representing developmental time points, 
and 14 months of age, representing a time point well into adulthood.  
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3.3 Materials and Methods 
3.3.1 Animals 
 Mice were prepared and handled as outlined in Section 2.3.1. Mice aged 14 
months and 21 days were all males, however animals 14 days of age used in this study 
were male and female. It was assumed that effects on estrogen on the mineralized tissues 
under study would be negligible at this age because mice do not reach sexual maturity 
until roughly 6 weeks of age (Vandenbergh, 1967) and no gender based differences in 
entheseal tissue have been described.   
 
3.3.1 Histology and Immunohistochemistry 
Histological techniques used in this study are as described in Section 2.3.2 with 
alterations. Fourteen month old mouse limbs were decalcified in 0.650M EDTA at 37 °C 
for 3 weeks, 21 day old animals were decalcified in the same solution for 2 weeks and 14 
day old animals were decalcified over the course of 7 days using this solution.  
In order to decrease background staining of the OPN and BSP antibodies at the 14 
and 21 day time points, an adaptation of the immunohistochemistry (IHC) protocol 
described in Section 2.3.2 was used. Antigen retrieval was not used on 14 and 21 day old 
samples. Antigen blocking was performed in 10% goat serum in phosphate buffer saline 
overnight at 4°C. In the morning primary antibody treatment with either rabbit anti-
mouse BSP serum (courtesy of Dr. Renny Franceschi, University of Michigan School of 
Dentistry, Ann Arbor, MI) or rabbit anti-mouse OPN serum (Courtesy of Larry Fisher, 
Bethesda, MD) was performed for 1 hour at room temperature and half the amount of 
antiserum was used.  
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Von Kossa staining was performed as described in Section 2.3.2, however, 
toluidine blue was used as a counterstain in these studies rather than alcian blue and 
nuclear fast red.  
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3.4 Results 
To better characterize the phenotype of the Bsp-/- murine enthesis, tissues from 
older mice, 14 months, and two juvenile time points, 14 and 21 days, were examined via 
histology.  
 
3.4.1 Age 14 months 
At age 14 months BSP and OPN can still be readily detected in the CFC of the 
QCT and SST enthesis and no differences in the distribution of OPN was observed in the 
Bsp-/- enthesis (Fig. 3.1 and 3.2). As previously shown, at age 15 weeks a 28% increase in 
the length of the QCT enthesis CFC was observed, measured tidemark to bone, in the 
Bsp-/- enthesis, while no differences were apparent in the morphology of the SST 
enthesis. At age 14 months, the QCT enthesis is further lengthened in the Bsp-/- mouse, 
while the size of the wild type CFC in the QCT enthesis did not change between 15 
weeks and 14 months of age (Table 3.1). The 14 month wild type CFC of the QCT 
enthesis displays an average increase of 30.2 µm from the 15 week Bsp-/- QCT enthesis 
and a 41% increase in size over wild type  (p<0.05, n=3)(Fig. 3.3). No changes were 
noted in the size of the SST CFC of Bsp-/- mice, aged 14 month. Collagen organization, as 
demonstrated by picrosirius red staining, remains unaffected by the loss of Bsp (Fig. 3.4).  
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Figure 3.1 BSP is present in the calcified fibrocartilage of 14 month-old mice.  
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST 
enthesis of 14 month old male wild type and Bsp-/- mice (n=3). Diaminobenzidine 
staining (brown) indicates the presence of BSP protein. CFC: calcified fibrocartilage, 
UFC: uncalcified fibrocartilage, bar = 100 μm  
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Figure 3.2 OPN is present in the calcified fibrocartilage of 14 month-old mice. 
Immunohistochemistry using anti-OPN antiserum was performed on the QCT and SST 
enthesis of 14 month old male wild type and Bsp-/- mice (n=3). Diaminobenzidine 
staining (brown) indicates the presence of OPN protein. CFC: calcified fibrocartilage, 
UFC: uncalcified fibrocartilage, bar = 100 μm  
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Figure 3.3 Calcified fibrocartilage of Bsp-/- is further lengthened with age. 
Hematoxylin and eosin staining of the QCT enthesis of male 14 month old wild type and 
Bsp-/- mice. CFC length (yellow arrow) is increased in the Bsp-/- mouse QCT enthesis 
compared to wild type (Table 3.1). CFC: calcified fibrocartilage, UFC: uncalcified 
fibrocartilage, T: tidemark, bar = 100 μm 
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Table 1. CFC lengths of 15 week and 14 month old wild type and Bsp-/- QCT 
entheses. CFC length was measured by drawing three transverses from tidemark to bone 
in the orientation of the collagen fibers per individual mouse by two blinded observers 
and averaged. Average CFC lengths from wild type and Bsp-/- mice were compared 
against each other using a two-tailed, unpaired, parametric t-test. Statistical analysis 
indicated significant differences (p<0.05) between genotypes within age groups. 
CFC Length (µm) Wild type Bsp-/- 
15 weeks (n=5) 178.8±15.5 µm 229.1±17.5 µm 
14 months (n=3) 182.9±23.7 µm 259.3±17.5 µm 
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Figure 3.4 At 14 months of age no differences in collagen organization are observed 
between wild type and Bsp-/- mice. Picrosirius red staining of the QCT and SST enthesis 
of 14 month old male wild type and Bsp-/- mice (n=3). Collagen fibres (bright objects) are 
well ordered in both wild type and Bsp-/- entheses. CFC: calcified fibrocartilage, UFC: 
uncalcified fibrocartilage, bar = 100 μm  
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3.4.2 Age 14 and 21 days 
General morphology of the QCT and SST enthesis of 14 and 21 day old wild type 
and Bsp-/- mice was assessed via hematoxylin and eosin (H&E) staining (Fig. 3.5 and 3.6). 
No gross morphological differences are apparent between wild type and Bsp-/- entheses. 
No tidemark is present in the H&E stains of these time points. At 14 days post-natal the 
cartilaginous anlage of the patella is just beginning to mineralize, and while the 
attachment point of the quadriceps tendon can be identified, von Kossa staining indicates 
that this region of the patella has not mineralized yet (Fig. 3.7). Mineral has reached the 
edge of the SST enthesis at 14 days of age but has not yet extended into the developing 
fibrocartilage (Fig. 3.7). At 21 days post-natal lamellar bone is beginning to form in the 
patella with some individual mice displaying more than others. A small band of mineral 
is present in the SST enthesis fibrocartilage (Fig. 3.8). Picrosirius red staining indicates 
that collagen content and organization is normal (Fig. 3.9 and 3.10). IHC using antibodies 
against OPN and BSP was performed on the murine SST and QCT enthesis at 14 and 21 
days post-natal (Fig. 3.11-3.14). BSP and OPN are restricted to the mineralized tissues at 
these time points and a thin band of BSP (weakly stained) and OPN can be seen adjacent 
to the bone in the SST enthesis, representing the developing mineralization front. Neither 
SIBLING proteins are present in the developing QCT enthesis at these time points.  
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Figure 3.5 No gross morphological differences are apparent in the entheses of 14 
day-old wild type and Bsp-/- mice. General morphology of the QCT and SST enthesis of 
14 day old male and female wild type and Bsp-/- mice was assessed by standard 
hematoxylin and eosin staining (n=5). Bar = 100 μm 
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Figure 3.6 No gross morphological differences are apparent in the entheses of 21 
day-old wild type and Bsp-/- mice. General morphology of the QCT and SST enthesis of 
21 day old male wild type and Bsp-/- mice was assessed by standard hematoxylin and 
eosin staining (n=5). Bar = 100 μm 
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Figure 3.7 Mineral is not present in the entheses of 14 day-old wild type and Bsp-/- 
mice. Whole tissue von Kossa staining was performed on the QCT and SST entheses of 
14 day old male and female wild type and Bsp-/- mice (n=5). Mineral deposition is 
represented in black. Sections are counterstained with toluidine blue.  Bar = 100 μm 
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Figure 3.8 Mineral is not present in the QCT enthesis of 21 day-old wild type and 
Bsp-/- mice however small amounts are present in the SST enthesis. Whole tissue von 
Kossa staining was performed on the QCT and SST entheses of 21 day old male wild 
type and Bsp-/- mice (n=5). Yellow circle demarcates the enthesis. Mineral deposition is 
represented in black. Yellow arrows indicate early sites of mineral deposition in the 
enthesis. Sections are counterstained with toluidine blue. Bar = 100 μm 
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Figure 3.9 At 14 days of age no differences in collagen organization are observed 
between wild type and Bsp-/- mice.  Picrosirius red staining of the QCT and SST 
enthesis of 14 day old male and female wild type and Bsp-/- mice (n=5). No apparent 
differences in the organization of collagen fibers (bright red/green) are present in wild 
type and Bsp-/- entheses. Bar = 100 μm 
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Figure 3.10 At 21 days of age no differences in collagen organization are observed 
between wild type and Bsp-/- mice. Picrosirius red staining of the QCT and SST enthesis 
of 21 day old male wild type and Bsp-/- mice (n=5). No apparent differences in the 
organization of collagen fibers (bright red/green) are present between wild type and Bsp-/- 
entheses. Bar = 100 μm 
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Figure 3.11 BSP is not present in the entheses of 14 day old wild type and Bsp-/- mice.  
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST 
enthesis of 14 day old male and female wild type and Bsp-/- mice (n=5). 
Diaminobenzidine staining (brown) indicates the presence of BSP protein. Bar = 100 μm  
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Figure 3.12 BSP is localized to mineralized regions in 21 day old wild type mice.  
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST 
enthesis of 21 day old male wild type and Bsp-/- mice (n=5). Diaminobenzidine staining 
(brown) indicates the presence of BSP protein. Bar = 100 μm  
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Figure 3.13 OPN is not present in the entheses of 14 day old wild type and Bsp-/- 
mice.  Immunohistochemistry using anti-OPN antiserum was performed on the QCT and 
SST enthesis of 14 day old male and female wild type, Bsp-/- and Opn-/-  mice (n=5). 
Diaminobenzidine staining (brown) indicates the presence of OPN protein. Bar = 100 μm  
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Figure 3.14 OPN is localized to mineralized regions in 21 day old wild type and Bsp-
/- mice.  Immunohistochemistry using anti-OPN antiserum was performed on the QCT 
and SST enthesis of 21 day old male wild type, Bsp-/- and Opn-/-  mice (n=5). 
Diaminobenzidine staining (brown) indicates the presence of OPN protein. Bar = 100 μm  
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3.5 Discussion  
In order to further elucidate the role of BSP in the fibrocartilaginous enthesis, a 
histological characterization of the BSP null enthesis was performed in mice of 14 days, 
21 days and 14 months of age. At 14 days BSP and OPN protein are not present in the 
QCT and SST entheses in wild type animal. At 21 days small amounts of BSP and OPN 
appear to be present near the bone in the SST enthesis, while no positive staining is 
observed in the QCT enthesis. Little change was observed in the general morphology, 
mineral deposition, collagen organization and OPN protein localization of Bsp-/- mice. At 
14 months of age immunohistochemical staining indicates no differences in the staining 
patterns of BSP and OPN from that observed at 15 weeks of age, and collagen 
organization remains unaffected by loss of BSP at age 14 months. Interestingly, the CFC 
of the QCT enthesis is further lengthened beyond measurements from 15 weeks of age, 
suggesting a dysregulation in the growth of this tissue in the absence of BSP.  
 
3.5.1 14 months 
 In captivity, mice live to two to three years of age. At the age of 14 month the 
only notable abnormality in the Bsp-/- mouse enthesis is the extension of the CFC 
observed in the QCT enthesis. As previously noted this phenotype was first observed at 
15 weeks of age, however the increase in CFC length is larger at 14 months of age. Wild 
type CFC length remains the same from 15 weeks to 14 months of age, suggesting that 
this tissue is fully mature by 15 weeks with outward growth of the mineralization front 
ceasing at some point prior. The increase in length of the Bsp-/- enthesis suggests that the 
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mineralized region continues to expand in the absence of BSP. BSP has traditionally been 
described as a promoter of mineralization, for which there is strong in vitro evidence 
(Hunter and Goldberg, 1993). However, in this instance BSP appears to be acting as a 
regulator of mineral growth, modulating the extent to which the mineralization front in 
the CFC extends outwards from the bone.   
 An analysis of the mineral content at the tidemark in the 14 month old Bsp-/- 
mouse by Raman spectroscopy is warranted, as the mineral gradient at 14 months may be 
steeper still. Unfortunately Raman spectroscopy could not be conducted on 14 month old 
animals at this time as the animals used in this study were taken from a preserved archive 
of mice maintained by our laboratory.  While animals kept in this fashion are suitable for 
histology, Raman spectroscopy requires fresh tissue, which could not be generated in a 
timely manner due to the age of the animals.  
 Future investigations at this time point should include mechanical studies on the 
Bsp-/- QCT as it may provide insight as to the functional significance of the lengthened 
CFC. Mathematical and mechanical modelling suggest that alterations in the length of the 
CFC in the magnitudes observed at this time point may result in weakening of the 
tendon-bone insertion due to the enlarged regions of presumably stiffer tissue, and if 
further abnormalities are present in the gradient region it may exacerbate the tendon 
defect further (Genin et al., 2009).  
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3.5.2 14 and 21 days 
 Due to BSP’s role in mineralizing tissues, the apparent similarities in growth plate 
development and enthesis development, and the deficiencies identified in endochondral 
ossification in the Bsp-/- mouse, it was hypothesized that BSP may play a role in enthesis 
development and mineralization. Furthermore, it was hoped that phenotypes caused by a 
loss of BSP would be more apparent during development. Entheses develop post-natally 
(Zelzer et al., 2014), and a mineral gradient is apparent in the SST enthesis as early as 14 
days postnatal (Schwartz et al., 2012). By 21 days the developing SST enthesis begins to 
resemble the morphology of the mature enthesis when examined histologically (Schwartz 
et al., 2012). Based on this knowledge, time points of 14 and 21 days of age were chosen 
for study. No developmental characterization of the mineral content of the developing 
murine QCT enthesis has been described.  
 In the fibrocartilaginous enthesis, BSP and OPN appear to be restricted to sites of 
mineralization. BSP and OPN’s absence in the extracellular matrix (ECM) of the 14 day 
old SST and QCT entheses is not surprising as these structures are not mineralized at this 
time point. Due to the lack of BSP in wild type tissues at 14 days of age, it is to be 
expected that the Bsp-/- mouse does not display an enthesis phenotype when examined 
histologically at this time point. At 21 days post-natal, mineral is just beginning to be 
deposited in the developing enthesis fibrocartilage in the SST, however no differences are 
apparent in general morphology, mineral deposition or collagen organization between 
wild type and Bsp-/- mice, consistent with our observations in mice 15 weeks and 14 
months of age. The mineralization front in the patella has not yet expanded into the QCT 
enthesis fibrocartilage by 21 days of age, and as such, neither BSP nor OPN are present 
120 
 
 
in wild type tissue. Unsurprisingly, no differences are apparent in 21 day old Bsp-/- QCT 
morphology.  
 Further characterization of the developing Bsp-/- enthesis is needed to elucidate 
BSP’s role in enthesis development. A histological characterization at 28 days post-natal 
is suggested, since at this time point mineral deposition in enthesis fibrocartilage is likely 
occurring. Further time points moving toward 15 weeks of age could also be assessed in 
order to determine at what age the Bsp-/- CFC length begins to outpace wild type tissue. 
 A major shortcoming in the histological analysis of BSP within enthesis tissue is 
the BSP antibody’s unfortunate affinity for cells located in uncalcified fibrocartilage, as 
well as muscle tissues. Our original IHC protocol used on 15 week old mice from our 
previous study and the 14 month old mice shown here, is effective in demonstrating BSP 
staining in the ECM. Intense brown staining is present in the CFC ECM of wild type 
animals while no ECM staining is observed in control Bsp-/- entheses. Cells located in the 
UFC however stain positive in both wild type and Bsp-/- mice, indicating that the BSP 
antiserum possesses some nonspecific binding activity. In the 15 week and 14 month old 
mice we were interested in showing that BSP is present in the ECM, and as cellular 
nonspecific staining is a common problem in IHC stains, this issue was not addressed at 
these time points. In the analysis of the 14 and 21 day old animals, where little mineral is 
present and uncalcified regions of fibrocartilage are more abundant, nonspecific cellular 
staining was much more evident. At these time points we were interested in whether BSP 
protein could be detected in the ECM and the cells of the developing enthesis, which 
would eventually become the CFC, however the non-specific staining prevented us from 
adequately addressing this question. A new protocol was developed for both BSP and 
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OPN antisera, which was intended to reduce the amount of nonspecific cellular staining. 
The altered protocol was effective in reducing nonspecific staining in OPN antiserum, 
however this protocol was less effective for the BSP antiserum, since it drastically 
reduced the staining intensity of both specific staining in bone and nonspecific cellular 
staining. Indeed, the BSP research field in general lacks an effective anti-BSP antibody. 
While numerous biotech companies claim to provide anti-BSP antibodies, none so far 
have produced an antibody that adequately meets the demands of all of the researchers in 
the field.  
 To conclude, these studies have shown that loss of BSP results in an increased 
lengthening of the CFC of the QCT entheses in 14 month old mice beyond what was 
observed in 15 week old animals. This observations suggests a defect in the regulation of 
CFC growth in the QCT enthesis in the absence of BSP. All other parameters measured 
in 14 month old mice remained unaffected by the loss of BSP. During development, BSP 
and OPN are not present in 14 day old murine entheses. In 21 day old entheses small 
amounts of these proteins may be present in the SST enthesis, but are absent in the QCT 
enthesis reflecting the amount of mineral present in entheses studied at these times. This 
observation suggests that BSP and OPN are restricted to mineralized sites in the enthesis. 
Further characterization at 28 and 42 days post-natal is warranted to uncover BSP’s role 
in enthesis development and mineralization.  
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CHAPTER FOUR 
 
GENERAL DISCUSSIONS AND CONCLUSIONS 
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4.1 Summary and Perspectives 
 Fibrocartilaginous entheses are transitional structures that connect tendons and 
ligaments to bone and contain a region of fibrocartilage with a mineralized component. 
Prior to these studies, mineral-associated proteins present in the calcified fibrocartilage 
(CFC) of the enthesis remained essentially uncharacterized and the mechanism by which 
mineral is deposited in enthesis fibrocartilage left unidentified. Bone sialoprotein (BSP) 
is an extracellular matrix protein commonly found in mineralizing tissues and has potent 
hydroxyapatite nucleating, collagen binding and cell signaling properties (Goldberg and 
Hunter, 2012). BSP has recently been implicated in the connection of periodontal 
ligament to the root of the tooth (Foster et al., 2013). The studies reported in this thesis 
have identified the presence of the mineral associated proteins BSP and OPN in the 
calcified tissues of the murine fibrocartilaginous enthesis in adult animals. Furthermore, 
it was shown that the loss of BSP results in abnormalities in the CFC of the quadriceps 
tendon (QCT) enthesis. Specifically, the CFC of the QCT enthesis in adult mice is 
elongated, and this elongation increases with age. Mineral content within the CFC was 
found to be comparable between Bsp-/- and wild type mice, as demonstrated by Raman 
spectroscopy and microCT. Collagen organization in the enthesis was not affected by the 
loss of BSP at any time point measured, in contrast to the phenotype observed in the 
periodontal ligament (Foster et al., 2013). During development, OPN and BSP are 
restricted to the mineralized regions of the enthesis. By 21 days of age, small amounts of 
mineral, along with BSP and OPN, can be detected in the fibrocartilage of the developing 
supraspinatus tendon (SST) enthesis. However, no phenotype is observed in the entheses 
of Bsp-/- mice at this time point, in line with observations in the adult animal. In the QCT 
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enthesis, mineral is not yet present in the enthesis fibrocartilage by 21 days post-natal and 
as such, BSP and OPN are not present at this time point and no phenotype is observed in 
the Bsp-/- mouse.  
 BSP has long been thought to be a promoter of mineralization, and there is strong 
in vitro evidence for its hydroxyapatite nucleating properties (Hunter and Goldberg, 
1993). Phenotypes in the Bsp-/- mouse such as delays in early mineralization in the long 
bones (Bouleftour et al., 2014; Holm et al., 2015); defects in bone repair after injury 
(Malaval et al., 2009); and acellular cementum deficiencies (Foster et al., 2013), are 
small, but also point towards BSP being a promoter of mineralization. The phenotype 
observed in the Bsp-/- enthesis, however, suggests a different role for BSP in this tissue. 
The extension of the QCT CFC indicates that more mineral, not less, is present in the 
Bsp-/- fibrocartilaginous enthesis. BSP’s expression at sites where mineralization is 
actively occurring has long been established (Bianco et al., 1991), and BSP is particularly 
abundant at mineralization fronts in bone (Bianco et al., 1993). Recently it was shown 
that active mineralization in the enthesis occurs in a narrow band of Indian hedgehog 
(IHH) producing cells at the tidemark and that there is little turnover in enthesis 
fibrocartilage once formed (Dyment et al., 2015). Thus is seems likely that BSP is active 
at the tidemark.  It would appear that at the enthesis mineralization front, BSP is acting as 
a regulator of mineralization, controlling mineral deposition at this site to ensure that the 
tissue is the appropriate size and the mineral gradient at the tidemark is properly formed. 
A delicate balance between pro- and anti-mineralization factors must occur at the 
tidemark, and the phenotypes observed in the Bsp-/- fibrocartilaginous enthesis suggest 
that BSP is one of possibly a number of factors active at this site. In BSP’s absence, the 
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balance is disrupted, with other pro-mineralization factors compensating for BSP, driving 
excess mineralization at the tidemark.  
 
4.2 Limitations of Research and Future Directions 
4.2.1 Phenotypic differences in different entheses and the role of muscle loading  
 A curious observation of these studies is that while alterations are present in the 
mineralized tissues of the QCT enthesis, there is an apparent lack of a phenotype in the 
SST enthesis. It is reasonable to assume that because both are fibrocartilaginous entheses, 
loss of BSP would result in the same phenotypic observations in both structures. 
However, in fibrocartilaginous entheses there are factors beyond biological and genetic 
ones that influence the structure’s development.  
The role of mechanical factors in the development of the tissues of the 
musculoskeletal system are well established (Galloway et al., 2013; Gkiatas and 
Lykissas, 2015), and the role of mechanical cues in the enthesis has been analyzed as 
well. In entheses that display a large change in insertional angle during joint movement, a 
larger region of uncalcified fibrocartilage (UFC) is observed (Benjamin and McGonagle, 
2001; Benjamin and Ralphs, 1998). Since this enthesis zone is more pliable than either 
tendon or the CFC, researchers have hypothesized that the increased amount of UFC aids 
in smooth movement of the joint during its total range of movement. Gao and Messer 
suggest that the size of the CFC is determined by the tensile load that the enthesis is 
under at puberty (Gao and Messner, 1996). When the shoulder muscles of newborn mice 
are paralyzed with botulinum toxin, decreased mineralization near the SST enthesis in the 
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bone was observed at 21 days of age and fibrocartilage failed to form at the insertion 
(Thomopoulos et al., 2007).  
Since the genetic factors at the QCT and SST entheses in the Bsp-/- mouse are the 
same, the anatomical location and function of these entheses must be considered. The 
muscles attached to the QCT are some of the largest and most powerful muscles in the 
body, in both mice and humans. Located on the anterior surface of the femur, they are 
involved in the extension of the leg and are used extensively during locomotion. The 
QCT inserts directly into the back of the patella rather than obliquely or by wrapping 
around another anatomical feature. As such, the tensile force on the QCT enthesis under 
load is large and the insertional angle is small. In contrast, the supraspinatus muscle is 
located in the shoulder and its contraction drives the initiation of abduction of the arm at 
the shoulder joint. The muscle is smaller than the quadriceps muscles and produces loads 
of a lower magnitude. Furthermore the SST makes contact with bone at an oblique angle, 
wrapping around the head of the humerus before inserting at the SST enthesis. As such 
the nature of the loads in the QCT and SST entheses are quite different, and these 
differences may be the cause of the discrepancies in phenotypes observed in the Bsp-/- 
mouse. In order to investigate the interplay between muscle load and BSP’s regulatory 
role in enthesis development, paralysis experiments, such as those described above, on 
the lower limbs of Bsp-/- mice should be considered.  
 
4.2.2 Establishing the expression of BSP in the enthesis 
 While these studies have established the presence of BSP and OPN protein in the 
enthesis, the question of whether these proteins are expressed in the enthesis remains 
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unanswered. Fibrochondrocytes of the enthesis have much in common with the 
chondrocytes of the growth plate (Zelzer et al., 2014), and BSP expression in 
hypertrophic chondrocytes has been demonstrated via in situ hybridization experiments 
(Bianco et al., 1991). It seems reasonable that the fibrochondrocytes of the CFC are the 
source of the BSP and OPN identified in the matrix.  However, observations in 14 and 21 
day old mice indicate that BSP and OPN are restricted to mineralized tissues in the 
enthesis, if present, and to bone, with no matrix staining present in the regions of the 
enthesis that have not yet become mineralized. BSP and OPN have a high binding 
affinity for hydroxyapatite (HA) (Goldberg et al., 2001), and as such, BSP and OPN 
could be expressed exogenously and become localized to the CFC by virtue of their 
acidic domains rather than being expressed endogenously within the tissue.   
In hopes of determining if BSP is expressed by enthesis fibrochondrocytes, real 
time quantitative PCR (qPCR) experiments were attempted but were ultimately 
unsuccessful.  In order to harvest mRNA from enthesis fibrochondrocytes for qPCR 
analysis, a laser capture microdissection (LCM) procedure was employed to specifically 
isolate fibrochondrocytes from the enthesis and avoid contamination with cells from bone 
and/or tendon. The LCM apparatus is a standard optical microscope equipped with a high 
power cutting laser and a low power catapult laser. It allows a user to examine a 
histological section and select specific regions to excise with the cutting laser. The 
excised specimen is then catapulted into a collection tube by the catapult laser for 
subsequent analysis.  
LCM is traditionally used on soft tissues to isolate specific cell types for qPCR 
analysis. Working with a mineralized tissue such as the enthesis present unique 
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challenges. Traditional histological analysis of mineralized tissue involves a lengthy 
decalcification process. The protocol used by our laboratory immerses tissue in high 
molarity EDTA for 3 weeks at 37 ˚C. Due to the unstable nature of RNA molecules, 
cryosectioning of fresh tissue prior to LCM is required to acquire sufficient mRNA yields 
for qPCR analysis. This necessitated the development of a method to section through 
solid patellae quickly to preserve RNA integrity while maintaining the structure of the 
tissue, so that the enthesis could be easily identified and excised during LCM. To 
overcome this obstacle we utilized a blade made of tungsten carbide, which is much 
harder than traditional stainless steel blades, which allowed us to cleanly cut fresh 
patellar sections without tearing the tissue. Although this method was ultimately not 
useful for obtaining RNA from entheseal tissue, it was critical to facilitate our Raman 
spectroscopy studies, which also required fresh, undecalcified tissue sections.   
qPCR functions on the premise that the amount of RNA present in a sample is 
proportional to the number of PCR cycles the sample must undergo before reaching a 
critical threshold (CT) in which the PCR amplification becomes exponential.  Data 
returned from qPCR analysis on enthesis fibrochondrocytes yielded CT values in the 
range of 30-40 PCR cycles, well beyond the range which is considered reliable (generally 
25 cycles or lower). This data indicates that very little to no RNA was present in our 
qPCR reactions, indicating a poor yield from the LCM extraction protocol. When 
considering the nature of the tissue under study and the process used, low RNA yield is 
understandable. Fibrocartilage in general is a hypocellular tissue, with each CFC section 
taken containing perhaps 40 cells. Several sections per individual were pooled together 
for qPCR analysis, however this did not appear to ameliorate the issue. Furthermore, 
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tissue used in this study was taken from animals 15 weeks of age. At this age the 
fibrochondrocytes of the CFC are mature and are not likely to strongly express matrix 
genes, and so BSP and OPN mRNA are likely sparse in these cells to begin with. This 
study highlights the many obstacles and difficulties present in conducting gene 
expression experiments on the mineralized tissues of the enthesis. Liu et al. did 
successfully perform qPCR analysis via LCM on enthesis fibrocartilage, however in this 
study tissue was taken from a developing enthesis in juvenile mice (age 14 days) and no 
mineralized tissue was present at this time (Liu et al., 2013). In situ hybridization is 
another commonly used technique to detect the presence of specific RNA molecules in 
tissues and our laboratory is currently pursuing experiments of this nature on enthesis 
fibrocartilage to establish BSP and OPN expression there.  
 
4.2.3 Other potential mineralization factors in the enthesis  
 In line with other mineralized tissues, excluding acellular cementum, loss of BSP 
in the enthesis does not cause a gross inability to form calcified tissue in the enthesis. 
Biomineralization is a complex and multifactorial process with a great deal of functional 
redundancy between the different players that regulate mineralization. Here we have 
identified two mineral associated proteins in the enthesis, and partially characterized the 
role of one factor involved in the formation of the CFC. In order to have a more complete 
understanding of the mechanism and regulatory network that controls formation of 
enthesis CFC, additional mineralization factors must be identified.  
 One potential candidate is dentin matrix protein 1 (DMP1), a fellow member of 
the SIBLING family with similar properties to BSP. Originally thought to be specific to 
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dentin, DMP1 has been identified in bone, cartilage and cementum as well (D’souza et 
al., 1997; Feng et al., 2003; George et al., 1995; Hirst et al., 1997; Macdougall et al., 
1998). DMP1 possesses an RGD integrin-binding motif (Kulkarni et al., 2000), and has 
been reported to bind collagen in the hole zones (He and George, 2004), and promote 
mineral deposition. Under some conditions DMP1 can act as a nucleator of HA formation 
(He et al., 2003); however, under other conditions it can act as an HA inhibitor 
(Silverman and Boskey, 2004). Thus, there is still controversy in the field regarding the 
role of DMP1 in mineralization. During the course of the studies outlined in this thesis, 
DMP1’s presence in enthesis fibrocartilage was probed as well. Immunohistochemistry 
revealed inconsistent results for DMP1 localization, with some entheses strongly staining 
for DMP1, while others stained weakly and in some no staining at all was detected. The 
presence or absence of staining did not correspond with BSP genotype and surprisingly, 
different entheses taken from the same mouse displayed different staining results. Further 
investigation is required to elucidate the reasons accounting for DMP1’s erratic staining 
pattern in the enthesis.  
 Another potential mineralization factor in the enthesis is asporin, so named 
because it is a member of the small leucine-rich repeat proteoglycan family which 
includes decorin and biglycan, and because it possesses a contiguous sequence of 
aspartate (Asp) residues in its N-terminal domain (Henry et al., 2001). Asporin binds type 
I collagen, which is competitively inhibited by decorin, indicating that the two proteins 
occupy the same binding site (Kalamajski et al., 2009). Asporin’s poly D sequence 
appears to possess calcium-binding properties (Kalamajski et al., 2009), similar to the 
properties conferred to BSP and OPN by their acidic domains (Goldberg et al., 2001). In 
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osteoblast cell culture, addition of asporin to culture media results in an increase in 
mineral nodule formation and expression of the osteoblastic cell markers osterix and 
Runx2, as shown by qPCR (Kalamajski et al., 2009). In a study of smoothen (Smo) 
knock-out mice, Liu et al. identified Aspn mRNA in developing enthesis fibrocartilage 
using RNAseq and qPCR. In mice in which the Smo gene is ablated (Smo-/-), enthesis 
fibrocartilage fails to mineralize and RNAseq and qPCR analysis indicate that there is a 
3.9 fold reduction in Aspn expression in Smo-/- enthesis fibrocartilage (Liu et al., 2013). 
Clearly asporin plays some role in the mineralization process of enthesis fibrocartilage 
however further studies are required, as the presence and localization of asporin protein 
in the enthesis has not yet been established.   
 Ultimately it is hoped that the search for factors and molecules that regulate 
mineral deposition and enthesis development will lead to advances in enthesis repair, 
specifically in tissue engineering. Numerous cell, growth factor and biomaterial based 
implants and grafts have been developed in an attempt to regenerate the complex 
transitional zones of the enthesis, however none so far have successfully created a 
biocompatible material with the same mechanical properties of the native enthesis (Lu, 
2013). Currently, the major hurdle in clinical translation of these therapies is successful 
integration of the graft into the existing musculoskeletal system. Given its cell binding 
properties and its apparent role in the regulation of the formation of the CFC, BSP may 
ultimately prove to be a useful molecule in the reattachment of tendons and ligaments 
into bone.  
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4.3 Conclusions 
 These studies have identified the SIBLING proteins BSP and OPN in the CFC of 
the murine fibrocartilaginous enthesis, showing for the first time the presence of these 
mineral associated proteins in the enthesis. The enthesis phenotype of mice that lack BSP 
was examined in order to elucidate the role of BSP in enthesis fibrocartilage. In the 
absence of BSP, the growth of the CFC appears to be dysregulated in the QCT enthesis, 
which continues to increase in size well into adulthood. In the absence of BSP, the body 
may compensates with an increase in the cross-sectional area of tendons in the Bsp-/- 
mouse. Due to the known properties of BSP, it may still be involved at the mineralization 
front of the fibrocartilaginous enthesis where it likely contributes to a complex network 
of proteins which act to control the growth of the CFC and regulate mineral deposition in 
the enthesis. As such, BSP may ultimately prove to be a useful molecule in the 
reattachment of tendons and ligaments into bone. 
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APPENDIX A 
 
Statement of Permission for the Use of Animals for Experimental Research. 
All animal experimentation was performed in compliance with the animal use protocol 
2008-092. This protocol is held by Dr. Harvey Goldberg, a principal investigator at the 
Schulich School of Medicine and Dentistry and the Department of Biochemistry at the 
University of Western Ontario, London, Ontario, Canada.  
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